Summary: Adenosine stress myocardial CT perfusion imaging with 128-slice dual-source CT in high-pitch mode allows for accurate detection of myocardial ischemia at a very low radiation dose © 2013 American Heart Association, Inc. 
Summary: This pilot study compared the diagnostic accuracy of myocardial perfusion imaging assessed by ultrafast (UF) singlephoton emission CT (SPECT) and standard (S) SPECT in a population of patients undergoing coronary or CT angiography. The authors evaluated regional myocardial ischemia in a head-to-head comparison using qualitative and quantitative analysis. On a per-patient basis, the authors' results showed similar diagnostic accuracy between the 2 approaches. On a per-vessel analysis, UF-SPECT resulted in a higher sensitivity for identifying obstructive coronary artery disease (CAD) than S-SPECT. Consequently, UF-SPECT resulted in a more-accurate delineation of multivessel CAD. If confirmed in larger studies, these findings may have important implications for diagnosis and for risk stratification of patients with known or suspected CAD.
Conclusions: This pilot study confirms that UF-SPECT provides high-quality fast myocardial perfusion imaging and suggests that it may allow a more-accurate evaluation of both extent and severity of myocardial ischemia in patients with coronary artery disease. 1 
Myocardial Perfusion Imaging After Coronary Artery Bypass Surgery Using Cardiovascular Magnetic Resonance
Summary: In the noninvasive assessment of coronary artery disease, though the diagnostic performance of qualitative methods is well established, quantitative measures potentially offer improved accuracy and greater objectivity in the serial assessment of myocardial perfusion. Most tracer-based imaging methods used for quantification of myocardial blood flow (MBF) use an arterial input function that is conventionally approximated by tracer changes within the left ventricular blood pool. In patients with coronary artery bypass grafting, this approach may prove problematic as dispersion of tracer in the bypass graft may result in significant modification of the arterial input function and lead to systematic underestimation of MBF. Such a possibility was investigated in this study, using cardiovascular magnetic resonance to test for bias in the measurement of resting MBF. The analyses revealed that in myocardial segments subtended by bypass grafts, there is no evidence of systematic underestimation of MBF by cardiovascular magnetic resonance. These findings can be extrapolated to other quantitative imaging techniques (such as positron emission tomography and contrast echocardiography) that use an arterial input function defined within the left ventricular blood pool. Therefore, the use of these quantitative methods for the evaluation of myocardial perfusion after coronary artery bypass grafting is justified.
In the clinical setting, these techniques may facilitate improved serial assessment and identification of hypoperfusion after bypass grafting.
Conclusions: Model-independent deconvolution analysis does not systematically underestimate blood flow in graft-subtended territories, justifying the use of this methodology to evaluate myocardial perfusion in patients with CABG. 2 
Risk Stratification and Prognosis of Human Immunodeficiency Virus-Infected Patients With Known or Suspected Coronary Artery Disease Referred for Stress Echocardiography
Summary: Patients with human immunodeficiency virus (HIV) infection are at an increased risk of accelerated coronary artery disease and subsequent cardiovascular events. The present study evaluated the prognostic value of stress echocardiography (SE) in patients with HIV infection and known or suspected coronary artery disease. Among 311 patients with HIV referred for SE, the presence of ischemia and scar detected by SE were independent predictors of cardiac events (cardiac death and nonfatal myocardial infarction). The presence of ischemia alone or ischemia and scar on SE was associated with a >3-fold and a 28-fold increase in risk of cardiac events. Furthermore, SE provided incremental prognostic value over traditional clinical, stress electrocardiographic, and resting echocardiographic variables. These findings indicate that even in this high-risk group of patients, SE identified a group of patients (normal SE) with a risk of cardiovascular events that was not different from the general population (event rate <1% per year) and in whom the use of more expensive and invasive testing or interventions can be avoided. Conversely, patients with an abnormal SE have a poor prognosis and may benefit from aggressive medical therapy and possibly coronary revascularization.
Conclusions: SE can effectively risk-stratify and prognosticate patients with HIV. The presence of ischemia and scar during SE provides independent and incremental prognostic value over traditional variables. A normal SE response portends a benign prognosis even in this high-risk subset.
by providing complementary coronary CT angiography. Its clinical utility may be significant in patients with a high coronary risk profile, known coronary artery disease, those with a high calcium score (eg, >400 Agatston Units), or those with suspected in-stent restenosis in whom severe coronary calcification or artifacts prevent accurate quantification of coronary stenosis by CT angiography. Additionally, in patients exhibiting intermediate (50% to 70%) coronary stenosis on coronary CT angiography, CT perfusion may be able to determine the hemodynamic significance of these lesions. Finally, in patients scheduled for coronary artery bypass surgery or percutaneous revascularization, information about both coronary lesion characteristics and myocardial segments with reversible ischemia or infarcts could be helpful to plan the procedure and provide prognostic information.
Conclusions: Adenosine-induced stress 128-slice dual-source highpitch myocardial CTP allows for simultaneously assessment of reversible myocardial ischemia and coronary stenosis, with good diagnostic accuracy as compared with CMR and invasive angiography, at a very low radiation exposure. 4 
Strain-Rate Imaging Predicts the Attenuation of Left Ventricular Remodeling Induced by Ischemic Postconditioning After Myocardial Infarction in Mice
Summary: Acute MI is a frequent pathology with severe adverse outcomes. Indeed, LV remodeling and myocardial dysfunction are associated with increased mortality and heart failure and are directly linked to MI size. This justifies the development of new therapeutic strategies, such as ischemic postconditioning, to reduce MI size, decrease long-term LV remodeling, and improve patient outcomes. In the setting of cardioprotective innovations, murine models of ischemia-reperfusion are increasingly used and allow a better followup assessment than large animal models. The development of mouse models of ischemia-reperfusion has led to the need for dedicated instruments for in vivo analysis. The novelty of the present study is to demonstrate that systolic SR, which correlates with MI size, is able to predict attenuation of LV remodeling by postconditioning.
Conclusions:
In this murine model of MI, SR accurately assessed the reduction in MI size induced by PC early after reperfusion and the subsequent reduction of LV remodeling. 5 
Rapid Detection of Coronary Artery Stenoses With Real-Time Perfusion Echocardiography During Regadenoson Stress
Summary: This study demonstrated that real-time myocardial contrast echocardiography could accurately detect myocardial perfusion abnormalities due to coronary artery disease after a bolus injection of the selective A2A receptor agonist regadenoson. Nearly all perfusion abnormalities could be visualized with real-time myocardial contrast echocardiography within the first 2 minutes of the bolus injection, with higher sensitivity than obtained with wall motion. No significant side effects occurred after regadenoson bolus injection. These findings indicate that regadenoson real-time myocardial contrast echocardiography appears to be a feasible, safe, and rapid noninvasive method for the detection of significant coronary artery stenoses. Unlike radionuclide imaging, no ionizing radiation is required, and the results are available to the physician and patient immediately. Although further multicenter clinical investigation is needed, the use of real-time myocardial contrast echocardiography with regadenoson may be an important alternative pharmacological stress echocardiography test in the future.
Conclusions:
Regadenoson real-time myocardial contrast echocardiography appears to be a feasible, safe, and rapid noninvasive method for the detection of significant coronary artery stenoses. 6 
Bright-Blood T 2 -Weighted MRI Has High Diagnostic Accuracy for Myocardial Hemorrhage in Myocardial Infarction: A Preclinical Validation Study in Swine
Summary: Myocardial hemorrhage after myocardial infarction (MI) usually goes undetected. T2-weighted cardiac MRI has the potential to detect myocardial hemorrhage because of the paramagnetic effects of deoxyhemoglobin. The authors have used an in vivo large animal model of reperfused MI which closely represents human MI to validate bright blood T2-weighted MRI for the detection of myocardial hemorrhage. MI was created in swine by occluding the left anterior descending coronary artery (n=10) or circumflex (n=5) for 90 minutes followed by reperfusion for ≤3 days (n=2), 10 days (n=7), or 60 days (n=6). MRI was performed at 1.5 T, using bright-blood T2-prepared steady-state free precession, T2*, and gadolinium-enhanced MRI. Left ventricular sections and histology were assessed for hemorrhage by an experienced cardiac pathologist blinded to the MRI data. Hypointense regions on T2-weighted and contrast-enhanced MRI were independently determined by 3 cardiologists experienced in MRI who were also blinded to the pathology results. In 80 images matched with histology, the positive and negative predictive values for pathological evidence of hemorrhage were 94% and 96% for T2-weighted, 84% and 53% for late gadolinium-enhanced MRI, and 84% and 56% for early gadolinium enhancement. The authors' results indicate that T2-weighted MRI has high diagnostic accuracy for myocardial hemorrhage. The heterogeneity of signal intensity associated with acute MI on T2-weighted MRI is partially due to intramyocardial hemorrhage. The authors' results are relevant to clinical practice since recent cohort studies have shown that myocardial hemorrhage is an independent predictor of adverse left ventricular remodeling after MI.
Conclusions:
Bright-blood T2-weighted MRI has high diagnostic accuracy for myocardial hemorrhage.
Left Ventricular Filling Pressure Assessment Using Left Atrial Transit Time by Cardiac Magnetic Resonance Imaging
Summary: Assessment of left ventricular filling pressure is of clinical importance in guiding therapy and evaluating prognosis in patients with systolic dysfunction. In this prospective study, the authors developed and applied a novel strategy for estimation of left ventricular filling pressure using mean circulation transit time in the left atrium by contrast-enhanced dynamic MRI. The normalized left atrial transit time not only predicted normal left ventricular filling pressures in control subjects but also differentiated between patients with and without hemodynamic derangement among those with left ventricular systolic dysfunction. Cardiac MRI is increasingly used in diagnosis and follow-up of patients with systolic dysfunction of various etiologies. This simple technique of single imaging acquisition with minute amount of gadolinium contrast can be complementary to any clinical or research study for comprehensive evaluation of patients with systolic dysfunction.
Conclusions: nLATT by cardiac MR is a promising new parameter of LV filling pressure that may provide graded noninvasive hemodynamic assessment. 9 
Echocardiographic Evaluation of Hemodynamics in Patients With Decompensated Systolic Heart Failure
Summary: The assessment of hemodynamics in patients with acute decompensated heart failure can be of value in their treatment. The authors evaluated the accuracy of Doppler echocardiography in estimation of left and right ventricular hemodynamics in 79 patients with unstable heart failure. The technique had a good accuracy in the estimation of stroke volume, pulmonary artery systolic and diastolic pressure, and mean right atrial pressure. Several Doppler indices, including tissue Doppler, had good accuracy in identifying patients with pulmonary capillary wedge pressure >15 mm Hg. In addition, the recent American Society of Echocardiography/European Association of Echocardiography guidelines were highly accurate in identifying patients with increased wedge pressure. In 12 repeat studies, Doppler echocardiography readily detected the changes in mean wedge pressure as well as other hemodynamic changes.
Conclusions: Doppler echocardiography provides reliable assessment of right and left ventricular hemodynamics in patients with decompensated heart failure. 10 
Dilatation and Dysfunction of the Right Ventricle Immediately After Ultraendurance Exercise: Exploratory Insights From Conventional Two-Dimensional and Speckle Tracking Echocardiography
Summary: It is well established that exercise has a significant benefit on an individual's health and longevity. The results of this study suggest a negative impact on right ventricular morphology and function after a prolonged bout of extreme exercise, which appears to influence changes in left ventricular filling. The acute changes are unlikely to require clinical intervention, particularly in view of their previously reported transient nature. That aside, the physiological adaptations identified in this study could help to elucidate the recently observed long-term right ventricular adaptations observed in the ultraendurance athlete. In view of this, there are 2 key points that the clinician may take from this study: (1) The findings should not influence any advice given to patients regarding the general health benefit of undertaking moderate, regular exercise, and (2) with the ever-increasing participation in extreme ultraendurance exercise, it is important in sports cardiology that the clinician is aware of these acute effects. These points provide greater insight that could influence patient management during and after such events, if required.
Conclusions: This exploratory study demonstrates RV dilatation and reduction in function after an ultramarathon. Further research is warranted to elucidate the mechanisms responsible for these findings. It is not clear what clinical impact might result from consecutive bouts of postexercise RV dysfunction.
11

Mechanisms of Abnormal Systolic Motion of the Interventricular Septum During Left Bundle-Branch Block
Summary: In a majority of patients with left bundle-branch block, there is abnormal leftward motion of the interventricular septum during isovolumic contraction, often referred to as septal beaking and septal flash when applying M-mode echocardiography and tissue Doppler, respectively. It has not been definitely determined if this abnormal motion is due to active septal contraction or if it is represents passive motion caused by an early rise in right ventricular pressure that pushes the septum leftward. The recent interest in quantification of dyssynchrony in patients who are candidates for cardiac resynchronization therapy has highlighted the importance of this distinction: If preejection septal motion is due to active contraction, it reflects timing of septal activation and should be included in left ventricular dyssynchrony assessment. If the motion is passive, however, it should not be used for timing of septal activation. The aim of this study was to differentiate between these mechanisms. In an animal model of left bundle-branch block, myocardial shortening was measured by sonomicrometry, electric propagation by implanted myocardial electrodes, and right and left ventricular pressures by micromanometers. The report concludes that the abnormal septal motion during preejection is a result of active septal contraction, unopposed by the late-activated left ventricular lateral wall. Whereas the magnitude of the preejection septal motion was modulated by changes in right and left ventricular loading, onset of septal shortening reflected septal activation regardless of loading conditions. These experimental data suggest that onset of preejection shortening rather than ejection phase indices should be used for timing of septal activation.
Conclusions: Leftward preejection motion of the septum during LBBB is mainly a result of active septal contraction, whereas alterations in diastolic ventricular pressures modulate the amplitude of this motion. The findings imply that the preejection phase should be included when assessing LV dyssynchrony. 12 
Relationship Between Early Diastolic Dysfunction and Abnormal Microvolt T-Wave Alternans in Patients With Type 2 Diabetes
Summary: In this pilot study, the authors have shown for the first time that early left ventricular diastolic dysfunction, as detected by tissue Doppler imaging, is independently associated with abnormal microvolt T-wave alternans, a marker of ventricular tachyarrhythmic events, in well-controlled type 2 diabetic patients without ischemic heart disease and left ventricular systolic dysfunction. Ventricular tachyarrhythmia episodes and the factors potentially responsible for triggering them are poorly understood, usually occur without warning or provocation, and result almost invariably in death. Therefore, efforts aimed at predicting and preventing sudden cardiac death have emerged as the major paradigm for addressing this significant unresolved public health dilemma.
Conclusions:
In this pilot study, the authors found that early diastolic dysfunction, as measured by tissue Doppler imaging, is independently associated with MTWA abnormality in T2DM individuals e34
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with normal systolic function. Further larger studies are needed to examine the reproducibility of these results. 13 
Echocardiographic Indices Do Not Reliably Track Changes in Left-Sided Filling Pressure in Healthy Subjects or Patients With Heart Failure With Preserved Ejection Fraction
Summary: Several modalities of echocardiography including Doppler, tissue Doppler, and color M-mode have shown promise in the estimation of left-sided filling pressures. Two such indices, E/e′ and E/Vp, have received recognition for their utility in the 1-time estimation of left-sided filling pressures in healthy subjects as well as select populations with cardiovascular disease. Some have extrapolated these findings, proposing the serial use of these indices to monitor changes in left-sided filling pressures in healthy research subjects or to titrate medical therapy in patients with heart failure. However, doing so would require demonstration that changes in noninvasive indices accurately track changes in left-sided filling pressures within individuals as filling pressures vary. To test this hypothesis, the authors made multiple, simultaneous measures of E/e′, E/Vp, and pulmonary capillary wedge pressure within healthy subjects and outpatients with heart failure with preserved ejection fraction as preload was manipulated using lower body negative pressure and rapid saline infusion. The key finding was that as left-sided filling pressures were manipulated, the relationships between E/e′ and pulmonary capillary wedge pressure and E/Vp and pulmonary capillary wedge pressure were highly variable, with individual subject linear regression slopes ranging from steeply negative to steeply positive and coefficients of determination ranging from very low to very high. In this study, noninvasive indices did not adequately track changes in left-sided filling pressures because these pressures varied within individual subjects. These findings raise concern about the use of these techniques in research studies with healthy volunteers or to titrate medical therapy in patients with heart failure with preserved ejection fraction.
Conclusions: Within individual subjects the noninvasive indices E/e′ and E/Vp do not reliably track changes in left-sided filling pressures as these pressures vary, precluding the use of these techniques in research studies with healthy volunteers or the titration of medical therapy in patients with HFpEF.
14
Fasting-Induced Myocardial Lipid Accumulation in Long-Chain Acyl-CoA Dehydrogenase Knockout Mice Is Accompanied by Impaired Left Ventricular Function
Summary: The main fuel for cardiac ATP production are longchain fatty acids, which are degraded through mitochondrial FAO.
Patients affected with inborn errors of long-chain FAO may present with hypertrophic cardiomyopathy. The pathogenesis of cardiomyopathy in long-chain FAO disorders is poorly understood, hampering the design of rational therapeutic strategies. Deficient oxidation of long-chain fatty acids may lead to accumulation of potentially lipotoxic metabolites. By applying in vivo cardiac MRI and 1H-MRS in the long-chain acyl-CoA dehydrogenase KO mouse model, the present study examines the effect of long-chain FAO deficiency on cardiac function and myocardial lipid levels. The authors show that, in fed conditions, the FAO-deficient heart is hypertrophied and harbors elevated levels of intracellular TG droplets. On fasting, myocardial TG levels further increased, accompanied by a reduced peak filling rate and a decreased left ventricular ejection fraction. These observations are in line with reports of decreased cardiac function on elevated myocardial TG levels in diabetic and obese humans. With the absence of signs for tissue fibrosis, the authors' results suggest that contractile dysfunction is induced by a metabolic effect of fasting. Further investigations of myocardial energy homeostasis in the long-chain FAO deficient heart are required before the detrimental effects of fasting can be fully attributed to lipotoxicity.
Conclusions: Using a noninvasive approach, this study reveals accumulation of myocardial TG in LCAD KO mice. Toxicity of accumulating lipid metabolites such as ceramides may be responsible for the fasting-induced impairment of cardiac function observed in the LCAD KO mouse.
15
Echocardiographic Variables After Left Ventricular Assist Device Implantation Associated With Adverse Outcome
Summary: A successful acute outcome after left ventricular assist device (LVAD) implantation depends on patient selection and the technical difficulty of surgery. However, how the authors treat the patients and LVAD settings may affect the patient outcome beyond the postsurgical period. In the present study, the authors retrospectively analyzed various variables in echocardiographic examinations performed 30 days after LVAD implant for their association with a compound end point (90-day mortality, readmission for heart failure, or New York Heart Association class III or higher at the end of the 90-day period). The authors found that mortality and persistent heart failure after LVAD surgery are predominantly associated with echocardiographic variables assessing the efficiency of unloading of the left ventricle and atrium, and those assessing right ventricular function. The only right ventricular variable significantly associated with adverse outcome was a decreased tissue Doppler velocity of the lateral tricuspid annulus. The variables assessing LV unloading, associated with adverse outcome were a high estimated left atrial pressure (>15 mm Hg) and a short mitral inflow deceleration time divided by the E wave velocity (<2 ms/[cm/s]). An interventricular septum deviated to the left was associated with worse outcome as well. In conclusion, echocardiographic variables suggestive of efficient but not excessive LV unloading are associated with favorable mid and long-term outcome after LVAD surgery.
Conclusions: Mortality and heart failure after LVAD surgery appear to be predominantly determined by echocardiographic evidence of inefficient unloading of the left ventricle and persistence of right ventricular dysfunction. Increased estimated LA pressure and short MDI are associated with worse mid term outcome. Leftward deviation of the septum is associated with worse outcome as well.
diminished in the group with no clinical events and that, when the left ventricular ejection fraction improved, hypokinetic or even dyskinetic segments recovered normal contractility. This improvement continued after 3 months, in agreement with the beneficial anatomic remodeling induced by CRT. Radionuclide ventriculographic phase may offer advantages compared with echocardiographic variables and singlephoton emission-computed tomography-based phase measurements in selecting patients for CRT. IVD is likely an important predictor of response to CRT. The threshold for IVD determined by receiver operating characteristic analysis in the present study requires prospective evaluation before generalized use in a heart failure population.
Conclusions:
The quantification of interventricular dyssynchrony with radionuclide phase analysis suggests that early postimplantation interventricular dyssynchrony may provide identification of CRT responders. Summary: To date, the inability to directly visualize ablation lesions during interventions is one of the main shortcomings in interventional electrophysiology. Conventional fluoroscopy provides insufficient soft tissue contrast, limited imaging capabilities of the heart and adjacent organs, and no spatial 3-dimensional information. Therefore, recovery of tachycardia after ablation due to unrecognized incomplete lesions is not uncommon, often resulting in the need for repeat procedures. Furthermore, there is little intraprocedural feedback on possible unintended ablation damage to adjacent organs. MRI has been proposed as a beneficial imaging modality for guiding electrophysiological procedures because it provides excellent soft tissue contrast and allows for 3-dimensional spatial imaging without exposing the patient and investigator to ionizing radiation. Recent reports describe successful MRI guidance of diagnostic electrophysiological investigations and even complex interventions such as AV-node modulation. Other studies have shown potential of MRI to visualize therapeutic lesions after radiofrequency ablation, mostly using delayed-enhancement imaging. The current study shows accurate visualization of ablation lesions in an animal model as well as in patients immediately after electrophysiological interventions. Not only contrast-enhanced but also nonenhanced MRI was feasible for immediate lesion visualization, which enables constant surveillance by repeated lesion imaging during interventions. Combining MRI catheter guidance with the ability to visually characterize myocardium and adjacent structures to discriminate viable tissue from lesions during ablation in real time has the potential to greatly improve safety and procedural success of electrophysiological interventions. Further technical improvements are expected to make real-time magnetic resonanceguided electrophysiological procedures a useful alternative to fluoroscopic guidance, especially for complex interventions.
MRI allows for precise lesion visualization in electrophysiological interventions just minutes after radiofrequency ablation. Nonenhanced T2-weighted MRI is particularly feasible for intraprocedural delineation of lesion formation as lesions are detectable within minutes after radiofrequency delivery and imaging can be repeated during interventions.
18
X-Ray Magnetic Resonance Fusion to Internal Markers and Utility in Congenital Heart Disease Catheterization
Summary: Fluoroscopy is the main imaging modality used to guide catheterization procedures. However, several limitations including poor soft tissue definition, the use of ionizing radiation, and lack of 3D data make this imaging modality suboptimal. In the x-ray magnetic resonance fusion (XMRF) modality, 3D MRI data are overlaid onto live fluoroscopic images during the catheterization procedure. This takes advantage of the high spatial and temporal resolution provided by fluoroscopy and the good soft tissue 3D anatomic information provided by MRI. However, to date, there has been no simple method to overlay MRI data onto fluoroscopy data. Current XMRF technology requires the use of external fiducial markers, specialized x-ray systems, or 3D rotational radiocontrast runs, which makes it impractical to perform XMRF on a routine clinical basis. The authors report on a new XMRF method that can now be done quickly with commercially available software, without the need for contrast, customized x-ray systems, or external fiducial markers. Furthermore, the method only uses minimal radiation, making it feasible to routinely perform XMRF during catheterization procedures. The authors have used this modality during congenital heart disease catheterization in 23 patients. The authors have found XMRF useful for roadmapping, angiographic camera angle selection, and for device positioning. This catheterization modality has the potential to significantly reduce radiation exposure and improve catheterization outcomes.
Conclusions:
Internal marker-based registration can be performed quickly, with minimal radiation, without the need for contrast, and with clinically acceptable accuracy using commercially available software. The authors have also demonstrated several potential uses for XMRF in routine clinical practice. This modality has the potential to reduce radiation exposure and improve catheterization outcomes.
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Circ Cardiovasc Imaging November 2013 dimensionless index, and aortic valve area, which is typically calculated by the continuity equation. Continuity equation utilizes left ventricular outflow tract (LVOT) diameter to calculate aortic valve area with the assumption that LVOT is circular. However, LVOT is very often elliptical in shape, potentially creating a discrepancy between the actual and calculated aortic valve area. The discrepancy is more noted in patients with reduced ejection fraction. The use of multidetector computed tomography enables us to 3-dimensionally measure LVOT area, which could be incorporated into the continuity equation.
The current study of patients with severe AS demonstrates that integration of 3D LVOT area significantly increases the congruence between various AS severity criteria (including corrected aortic valve area, transaortic gradients, and dimensionless index), leading to improved classification of AS severity, especially in the setting of reduced ejection fraction. Improved congruence in aortic valve area measurements could help in selection of appropriate timing for surgical and percutaneous treatments. In addition, it could also help in further refinements in shape and size of future percutaneous aortic valves.
Conclusions:
In patients with suspected severe AS, incorporation of MDCT-LVOT area into CE improves congruence for AS severity. Summary: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in both men and women. The authors found that (1) coronary artery calcium (CAC) was most strongly associated with coronary heart disease and total CVD, (2) left ventricular (LV) mass and concentric remodeling best predicted stroke, and (3) LV mass best predicted heart failure. Refining the role of potentially competing bioimaging tests in CVD risk assessment can guide the selection of the optimal screening test for a given population. Although CAC best predicted overall incident CVD events, it may be more relevant in populations where coronary heart disease is common, and LV mass and concentric remodeling may be more suitable if demographics and risk factor profile favor an increased likelihood of subsequent heart failure or stroke. Practical considerations such as cost, availability, patient preference, local expertise, and technological limitations are important factors that also may dictate the potential choice among these imaging measures. Although the number of events in women was limited, the results provide population-based evidence that the independent prognostic utility of CAC, LV mass, and LV concentric remodeling in women is similar to men and suggest that CAC offers incremental risk prediction beyond traditional risk factors in women as in men. Like sex, imaging tests also may have a similar ability of risk stratification across different ethnicities.
Conclusions: There was no evidence that imaging measures differed in association with incident CVD by sex. CAC was most strongly associated with CHD and CVD; LV mass and LV concentric remodeling best predicted stroke; and LV mass best predicted HF. Summary: Coronary computed tomography angiography (CCTA) has been shown to be a sensitive and specific tool for the detection of significant coronary stenosis and has also allowed for the visualization and characterization of coronary plaque subtypes. Several studies have demonstrated that CCTA can provide prognostic information in patients with suspected coronary heart disease. Studies have also provided insight as to what specific plaque subtypes and characteristics might be associated with poor outcomes. Concurrently, highsensitivity C-reactive protein (hsCRP) has also been proposed as a method of identifying individuals at higher cardiovascular risk and has been shown to allow for the independent and improved risk stratification beyond traditional risk scoring systems. The authors sought to analyze the relationship between elevated levels of hsCRP and plaque subtypes as identified by CCTA. Increasing levels of hsCRP were found to be associated with the prevalence and extent of any mixed calcified plaque and the presence of significant coronary stenosis. The authors' results suggest that the increased cardiovascular risk associated with increased levels of hsCRP could be due, at least in part, to a higher prevalence of mixed calcified plaque, which has been shown to have some of the key elements observed in unstable coronary plaques.
Conclusions: Elevated levels of CRP are associated with an increased prevalence of MCAP as assessed by coronary computed tomography angiography. Longitudinal studies will determine if the excess risk observed in persons with elevated CRP may be mediated, at least in part, by an increased burden of MCAP.
23
Long-Term Improvement in Postinfarct Left Ventricular Global and Regional Contractile Function Is Mediated by Embryonic Stem Cell-Derived Cardiomyocytes
Summary: Unlike most adult stem or progenitor cells, pluripotent stem cells derived from embryos (embryonic stem cells, ESCs) or experimentally from somatic cells (induced pluripotent stem cells) provide a nearly-unlimited source of cardiomyocytes (CMs) for cellular cardiomyoplasty. In this study, highly enriched CMs derived from murine ESCs were generated in large quantities for in vivo evaluation in a rat myocardial infarction model. Characterization of these cells suggests that they expressed all cardiac markers and resembled early-stage CMs. By cardiac magnetic resonance, the authors examined the ability of ESC-CMs to improve global and regional contractile function during postinfarction remodeling. Engraftment of ESC-CMs improved global systolic function of infarcted hearts 1 and 2 months after injection and increased regional contractile function. No teratoma was observed in any of the treated animals. Immunohistochemistry confirmed formation of grafts and revealed expression of α-smooth muscle actin in grafted ESC-CMs. Connexin-43-positive sites were observed between grafted ESC-CMs, but only infrequently between grafted and host CMs, suggesting suboptimal cellular coupling between grafts and host myocardium. In summary, cardiac magnetic resonance provides a powerful quantitative tool for assessment of cellular cardiomyoplasty and facilitates direct comparisons of left ventricular functional improvement among scientific laboratories worldwide. The approaches used in this study can be applied to induced pluripotent stem cells, which overcome major constraints associated with the use of human ESCs.
Conclusions:
Highly enriched and early-stage ESC-CMs were safe, formed stable grafts, and mediated a long-term recovery of global and regional myocardial contractile function after infarction.
24
Impaired ATP Kinetics in Failing In Vivo Mouse Heart
Summary: Energy metabolism fuels ongoing myocardial contraction, and altered metabolism may contribute mechanistically to several cardiac diseases including heart failure. 31P magnetic resonance spectroscopy is the only means to noninvasively quantify the levels of myocardial high-energy phosphates, adenosine 5′-triphosphate (ATP) and creatine phosphate. Magnetization transfer 31P magnetic resonance spectroscopy methods were adapted in recent years to measure the rate of ATP turnover in the human heart. Such 31P magnetic resonance spectroscopy techniques, when combined with magnetic
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Editors' Pick: Most Important Articles in Cardiovascular Imaging Science, Part II e37 resonance imaging approaches, offer a powerful means to assess cardiac energy metabolism, structure, mass, and contractile function in the same examination. Murine models are increasingly used to probe molecular mechanisms of human disease because of the possibility of creating specific transgenic lines. However, the small size (~0.1 g) and high rate (~600/min) of the mouse heart present significant challenges for noninvasive imaging approaches. In this report, the first noninvasive in vivo measures of the rate of ATP synthesis through creatine kinase, the major myocardial energy reserve, in the murine heart are reported. They demonstrate that ATP turnover rates in normal and failing mouse hearts are comparable to those reported in human hearts. This validated, noninvasive approach to measuring ATP synthesis rates through creatine kinase in the intact mouse can be combined with anatomic and functional measures in the same examination and be repeated over time as pathology develops. The observations demonstrate that murine models recapitulate several fundamental aspects of human myocardial energy metabolism in vivo and support their use to probe specific metabolic contributions to the development and progression of heart failure.
Conclusions: Despite the small size and high murine heart rate, the ATP synthesis rate through CK is similar in vivo in murine and human hearts and comparably reduced in HF. Because murine thoracic aortic constriction shares fundamental energetic similarities with human HF, this model and new magnetic resonance spectroscopy approach promise a powerful means to noninvasively probe altered energetics in HF.
25
Influence of Diabetes Mellitus on Prognostic Utility of Imaging of Myocardial Sympathetic Innervation in Heart Failure Patients
Summary: Patients with diabetes mellitus have accelerated progression of heart failure (HF). The present study examines the implications for HF progression of cardiac sympathetic denervation, assessed by I-123 metaiodobenzylguanidine (MIBG) imaging. HF progression (defined as increase in New York Heart Association class) during a median follow-up of 17 months was examined in 343 diabetic and 618 nondiabetic subjects with New York Heart Association class II or III heart failure and a left ventricular ejection fraction ≤35%. By multivariable Cox proportional hazards model, the variables associated with time to an HF progression event were b-type natriuretic peptide, left ventricular ejection fraction, late I-123 MIBG heart-to-mediastinum (H/M) ratio, the interaction term diabetes mellitus with late H/M ratio, early H/M ratio, and New York Heart Association class. The presence of a late H/M ratio <1.6 was associated with a 2.99-fold increase in the risk of HF progression in diabetic subjects. Conversely, there was no difference in the risk of HF progression between diabetics and nondiabetics if the late H/M ratio was ≥1.6, indicating relatively preserved cardiac sympathetic innervation. These findings indicate that cardiac sympathetic nerve dysfunction increases the risk of HF progression in patients with diabetes mellitus. Therefore, treatments designed to prevent or ameliorate cardiac sympathetic denervation in diabetic subjects (eg, β-adrenergic-blocking drugs) may provide additional benefit for prevention of HF progression beyond those therapies focused primarily on treatment of diabetes.
Conclusions:
The combination of diabetes mellitus and I-123 metaiodobenzylguanidine H/M ratio is an independent predictor of heart failure progression, confirming the high risk of diabetic subjects with impaired cardiac sympathetic nerve function.
26
Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia: The Effect on Diastolic Function
Summary: Bone marrow cell therapy has emerged as a potential therapeutic option for patients with chronic ischemic heart disease.
In patients with chronic myocardial ischemia, improvements in myocardial perfusion and left ventricular (LV) systolic function have been documented after intramyocardial bone marrow cell injection. However, only limited data are available on the effect of bone marrow cell injection on diastolic function. The current substudy of a randomized trial evaluated the effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia. In 50 patients (25 in the bone marrow cell group, 25 in the placebo group), diastolic function was evaluated using standard echocardiography, speckle tracking strain analysis, and MRI (in a subset of patients). At 3 months follow-up, modest improvements were observed in the parameters of myocardial relaxation and filling pressure in bone marrow cell-treated patients. In placebo-treated patients, no changes were detected in the parameters of diastolic function.
Conclusions:
The current study demonstrates that intramyocardial bone marrow cell injection is associated with a beneficial effect on myocardial relaxation and filling pressures in patients with chronic myocardial ischemia.
27
MRI of Coronary Wall Remodeling in a Swine Model of Coronary Injury Using an ElastinBinding Contrast Agent
Summary: Coronary magnetic resonance vessel wall imaging has been used successfully to assess positive remodeling in patients with coronary artery disease and to demonstrate increased vessel wall thickness in patients with type I diabetes and microalbuminuria. This technique remains challenging because it requires high spatial resolution and motion compensation. Alternatively, contrast-enhanced coronary vessel wall imaging reduces the imaging task to the detection of contrast uptake, thereby lowering the requirements on spatial resolution and motion correction. The use of target-specific contrast agent would combine the advantages of contrast enhanced coronary vessel wall imaging while also providing information on important biological processes such as inflammation or extracellular matrix remodeling. Atherosclerosis and in-stent restenosis are accompanied by extracellular matrix synthesis or degradation. Because elastin is an important component of the extracellular matrix, an elastin-specific contrast agent may facilitate the noninvasive detection of extracellular matrix formation or degradation.
Conclusions: The authors demonstrate the noninvasive detection and quantification of vascular remodeling in an animal model of coronary vessel wall injury using an elastin-specific MR contrast agent. This novel approach may be useful for the assessment of coronary vessel wall remodeling in patients with suspected coronary artery disease. Further studies in atherosclerotic animal models and degenerative ECM disease are now warranted. Although changes in LV geometry can be clinically assessed using a variety of imaging modalities, these images do not address fundamental underlying mechanisms that contribute to LV dilation after MI. A number of animal studies have demonstrated a causal relationship between LV dilation after MI and activation of the matrix metalloproteinases (MMPs). In the present study, a technetium-99m-labeled compound (99mTc-RP805) designed to bind to the catalytic domain of a number of MMPs was used to image in vivo MMP activation after MI. The myocardial spatial distribution and specificity of this MMP-targeted compound was validated through direct comparisons with ex vivo immunoblotting and zymography for the determination of regional MMP levels and activity. Regional in vivo MMP activation also was correlated with temporal changes in regional myocardial strain and post-MI remodeling. The post-MI change in LV end-diastolic volumes correlated with MMP activity. High-quality in vivo images of 99mTc-RP805 retention were obtained on a standard clinical hybrid single-photon emission CT/CT system, suggesting that this approach holds potential for extension to imaging MMP activation in patients after MI, with potential value for risk stratification and directing therapy.
Conclusions: A novel, multimodality, noninvasive hybrid SPECT/CT imaging approach was validated and applied for in vivo evaluation of MMP activation in combination with cine MR analysis of LV deformation. Increased 99mTc-RP805 retention was seen throughout the heart early post-MI and was not purely a reciprocal of thallium-201 perfusion. The 99mTc-RP805 SPECT/CT imaging may provide unique information regarding regional myocardial MMP activation and predict late post-MI LV remodeling. Evaluation in this study showed that LMI1195 exhibited NET affinity and NET-mediated cell uptake kinetics similar to norepinephrine in vitro and high selectivity to the transporter in vivo. The cardiac image quality was considered excellent, with low and/or rapid clearance of radioactivity in adjacent organs. In addition, cardiac denervation and progression of HF could be detected by LMI1195 imaging in animal models. In clinical studies, assessment of NET function by cardiac imaging with similar agents has demonstrated the potential to stratify HF patients for treatment. However, the currently available imaging agents have poor image quality with the use of a gamma camera or are labeled with a short half-life radioisotope unsuitable for commercial use. LMI1195 labeled with 18F takes advantage of superior PET image quality and is available for central supply, like 18F-FDG. Thus, LMI1195, with an improved imaging profile, should be able to provide more quantifiable information in disease prognosis, risk stratification, and treatment selection (such as which patients with HF prone to ventricular arrhythmia and death benefit from costly, invasive, but potentially effective implantable cardiac defibrillators) in patients with HF.
Conclusions: LMI1195 is a novel 18F imaging agent retained in the heart through the NET and allowing evaluation of the cardiac sympathetic neuronal function by PET imaging.
31
Dual Manganese-Enhanced and Delayed Gadolinium-Enhanced MRI Detects Myocardial Border Zone Injury in a Pig IschemiaReperfusion Model Summary: Improved survival of patients with ischemic cardiomyopathy with coronary revascularization has been well documented. Clinically, the assessment of viable myocardium is crucial for determining which patients will benefit from revascularization. Gadolinium-based delayed-enhancement MRI (DEMRI) is considered a gold standard for imaging myocardial viability. Transmural DEMRI signal is believed to indicate irreversible myocardial injury; however, DEMRI signal is not specific for cell viability and may overestimate true myocardial infarct volumes by nearly 15% in some studies. In the present study, the authors demonstrate a novel, dual-contrast MRI strategy to noninvasively characterize the injured border zone of the myocardium postinfarction. Manganese is an essential metal cation that is avidly taken up by live myocardial cells. Manganese-enhanced MRI (MEMRI) signal is, therefore, a specific marker for viable cardiomyocytes, producing a bright T1 signal in live myocardium and a signal defect in infarcted myocardium. Adult Yorkshire pigs underwent 1-hour ischemia-reperfusion injury and were imaged by cardiac MRI 21 days later with MEMRI and DEMRI sequences. Both contrast agents correlated well with histopathological scar volume; however, MEMRI infarct volume was significantly (39%) smaller than DEMRI infarct volume. There was significant overlap in positive signal from MEMRI and DEMRI, and these overlap regions showed intermediate signal-to-noise ratio and preserved cytoarchitecture by tissue electron microscopy, indicating that live cells may reside within regions of transmural DEMRI-positive myocardium. The potential clinical impact of this novel imaging strategy is significant because MEMRI-DEMRI dual contrast may provide complementary information on complex, heterogeneous border zone biology that could help to guide therapy for patients with ischemic heart disease.
Conclusions:
The dual-contrast MEMRI-DEMRI detects BZ viability within DEMRI infarct zones. This approach may identify injured, atrisk myocardium in ischemic cardiomyopathy. Tc-sestamibi and, hence, could be a useful agent to image myocardial blood flow in humans.
The ability of 123 I-ZIROT to more linearly track blood flow over a wide range makes it a promising new SPECT myocardial perfusion imaging agent with potential for improved coronary artery disease detection and better quantitative estimation of the severity of flow impairment. , that Gd-TO robustly images acute necrotic cell death in vivo. Although uptake of Gd-TO was seen within 2 hours of infarction, peak uptake occurred 9 to 18 hours after MI. This pattern parallels the release of troponin by cardiomyocytes and suggests that cardiomyocyte rupture peaks many hours after the onset of myocardial ischemia. No uptake of Gd-TO was seen in mice injected with the agent more than 72 hours after MI. This suggests that necrotic cells are rapidly and efficiently cleared from the myocardium within 72 hours of injury. Gd-TO provides a readout that is specific for acute (<72 hours) necrotic cell death and can be used to assess the kinetics, mechanism (apoptosis versus necrosis), and chronicity of cell death in vivo. Current techniques such as delayed enhancement and T2-weighted MR imaging, while of major value, are not specific for cell death and may not be able to differentiate acute (<72 hours) from subacute (<30 days) injury. Gd-TO thus has the potential to become a useful clinical tool and play an important role in the diagnosis and characterization of cell death.
Conclusions: Gd-TO specifically binds to acutely necrotic cells and can be used to image the mechanism and chronicity of cell death in injured myocardium. Cell rupture in acute MI begins early but peaks many hours after the onset of injury. The ruptured cells are efficiently cleared by the immune system and are no longer present in the myocardium 72 hours after injury. Summary: Degenerative mitral valve disease (DMVD) frequently includes different degrees of annular dilation, leaflet redundancy, and chordal dysfunction, which result in variable cardiovascular morbidity and mortality. DMVD encompasses 2 broad categories, fibroelastic deficiency and Barlow disease. Accurate diagnosis of these entities along with their specific location and complexity is important because they require different surgical planning, which necessitates careful matching between the complexity of reparability and surgical expertise. Differential diagnosis in DMVD is challenging because it relies on qualitative evaluation that requires a high level of expertise. Quantitative decision support would be useful in assessing key anatomic features of DMVD and therefore guide appropriate surgical strategy. This is the first comprehensive study to characterize DMVD objectively using real-time 3D echocardiography. The authors sought to describe the pathomorphology of the MV in DMVD and to identify real-time 3D echocardiography parameters that can accurately characterize DMVD. The authors' results have yielded a systematic approach to differentiating DMVD from normal valves and importantly Barlow disease from fibroelastic deficiency before surgery. In the proposed algorithm, DMVD can be differentiated from normal valves based on billowing height, whereas billowing volume can be used to distinguish between Barlow disease and fibroelastic deficiency patients. Use of this quantitative algorithm makes early differentiation feasible and the diagnosis more objective and less experiencedependent, highlights quantitative anatomic differences between the groups, and provides a framework for preoperative assessment of the complexity of repair. As quantification tools become more automated and less reliant on expertise, they may be used to support clinical decision-making by a wider group of physicians.
Morphological analysis as a form of decision support in assessing MV billowing revealed significant quantifiable differences between NL, FED, and BD patients, allowing accurate classification of the etiology of MV prolapse and determination of the anticipated complexity of repair. Summary: Despite significant improvements in the management of heart failure, morbidity and mortality remain high. The comorbid association of right ventricular (RV) dysfunction with left heart failure identifies patients with a particularly poor prognosis. There has been recent clinical interest in the role of metabolic modulation in the treatment of left ventricular dysfunction. An understanding of the metabolic changes in the right ventricle may serve as a potential target for the management of RV failure. This study was designed to characterize myocardial metabolism in the right ventricle of patients with left ventricular failure. RV dysfunction was associated with an increase in RV glucose uptake. This metabolic change was correlated with the severity of RV dysfunction. Larger, prospective studies are required to define the potential clinical implications of this metabolic adaptation.
Conclusions: RV dysfunction is associated with an increase in RV FDG uptake, the magnitude of which may be correlated with severity.
36
Regional Thicknesses and Thickening of Compacted and Trabeculated Myocardial Layers of the Normal Left Ventricle Studied by Cardiovascular Magnetic Resonance
Summary: Whether an individual who has been found to have unusually prominent or extensive left ventricular (LV) trabeculations should be regarded as having pathological LV noncompaction has become a recurring dilemma for cardiologists and imaging specialists. This dilemma has arisen partly through improvements in imaging and partly through growing awareness of LV noncompaction as a possible pathological entity. Solution of the dilemma requires methodical study of normal ranges of image appearances to compare with those found in a patient by the same modality, and CMR often is the modality chosen to resolve the issue. The current study reports, for the first time, the segmental incidence of visible trabeculations and the segmental ranges of the thicknesses of the trabeculated relative to the compacted layers, as measured at end diastole and end systole in routine short-axis cine CMR in 120 healthy volunteers spanning 6 deciles of adult life. The measurements give novel insights into the prevalence, segmental distribution, dynamics, and likely functional role of the trabecular myocardial layer. The systolic thinning of the apparent trabeculated layer, in contrast to the marked thickening of the apparently compact myocardium, is discussed. It supports a functional role for trabecular rather than compact myocardial structure in certain endocardial regions and suggests, as others have previously, that changes associated with a dilated cardiomyopathy may in themselves lead to, and not necessarily result from, an abnormally high ratio of visibly trabeculated to compacted myocardial thickness.
Conclusions:
The authors demonstrated age-and sex-related morphometric differences in the apparent trabeculated and compacted layer thicknesses and systolic thinning of the visible trabeculated layer that contrasts with compacted myocardial wall thickening.
37
Late Gadolinium Enhancement Magnetic Resonance Imaging in the Diagnosis and Prognosis of Endomyocardial Fibrosis Patients
Summary: The authors evaluated the role of late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) for the diagnosis of endomyocardial fibrosis (EMF) using surgical specimens as the standard method. LGE-CMR confirmed the diagnoses of EMF patients on the basis of areas of LGE that were confined to the endocardium as continuous stria from the inflow tract to the apex. Histopathology of fibrous tissue in 14 patients showed typical features of EMF. The authors' study provides evidence that LGE-CMR is a reliable diagnostic tool to confirm EMF.
Conclusions:
The authors' study provides evidence that LGE-CMR is useful in the diagnosis and prognosis of EMF through quantification of the typical pattern of FT deposition.
38
Mechanisms of Acute Mitral Regurgitation in Patients With Takotsubo Cardiomyopathy: An Echocardiographic Study
Summary: Despite the favorable outcome of takotsubo cardiomyopathy (TTC) in general, the presence of significant acute mitral regurgitation (MR) increases the risks of acute deterioration and adverse outcome in TTC. However, the mechanism of acute MR in TTC remains unclear. In this study, the authors elucidated the mechanisms of acute MR in TTC; apical tethering and systolic anterior motion of the mitral valve are 2 independent mechanisms that can lead to acute MR in TTC. The authors' finding of simultaneous improvement of apical tethering and MR severity in the patients with TTC is particularly important for the understanding of the mechanism of acute MR. Based on the study results, TTC should be regarded as a potential cause of acute MR. In addition, pulmonary artery systolic pressure is significantly higher in patients with TTC with MR than in those without MR. Therefore, early detection of MR is important for proper management of patients with TTC. The current American College of Cardiology/American Heart Association guidelines recommend mitral valve surgery in symptomatic patients with severe acute MR; however, the present results support the idea that aggressive medical treatment of TTC would be the first priority because acute MR in TTC is reversible. These findings imply that echocardiography should be systematically performed in patients with TTC to identify MR and assess its mechanism.
Conclusions: SAM and tethering of the mitral valve are independent mechanisms with differing pathophysiology that can lead to acute MR in patients with TTC.
39
Mitral and Tricuspid Annular Velocities Before and After Pericardiectomy in Patients With Constrictive Pericarditis
Summary: The diagnosis of constrictive pericarditis often is challenging even after multiple diagnostic tests. Tissue Doppler imaging of the mitral annulus has facilitated the identification of constriction, which potentially is curable by pericardiectomy. Preserved or augmented medial annulus early diastolic velocity in a patient with heart failure and normal ejection fraction points to the diagnosis of constriction. However, this finding is not that helpful in young patients who normally have preserved early diastolic mitral annulus velocity. The additional finding of lower mitral lateral annulus early diastolic velocity compared with the medial annulus increases confidence in the diagnosis of constriction. Although normal or increased mitral medial annulus velocity strongly suggests the diagnosis of constriction, it may be reduced if there is superimposed myocardial disease. Even in this situation, the mitral lateral annulus velocity usually is lower than that at the medial annulus. The fact that annular velocities return to lower values after pericardiectomy confirms that the characteristic annulus velocity pattern observed is a product of constrictive pericardium. The authors need to take advantage of this simple measurement when evaluating a patient with heart failure and normal left ventricular ejection fraction.
Conclusions:
The mitral lateral/medial e′ ratio is reversed in three fourths of patients with CP. All annular velocities are lower in secondary compared to primary CP before pericardiectomy. After pericardiectomy, there is reduction of all annular velocities and normalization of the mitral lateral/medial e′ ratio. Summary: MRI can define the anatomic extent of hypertrophy, global ventricular function, and regional wall thickening, with cine MRI providing high-quality information comparable to 2D and 3D echocardiography. Displacement encoding with stimulated echoes (DENSE) is an MRI-specific method for quantifying myocardial strain with physics intrinsically similar to myocardial tagging methods but at higher resolution. DENSE allows quantification of both in-plane directions of motion and, although not implemented in this study, also through plane motion, and minimizes artifacts caused by through-plane motion of tissue. Late gadolinium-enhanced MRI can detect myocardial fibrosis. These methods were used in the current study to examine the intramural relationship between fibrosis and regional contractile function in 22 patients with hypertrophic cardiomyopathy. Intramural systolic Summary: LA enlargement is common in chronic MR and is emerging as an important prognostic marker. However, the outcome implications of LA enlargement have not been analyzed in the context of routine clinical practice and in a multicenter study. The present analysis of the MIDA registry aimed to establish whether LA diameter, a simple measure of LA enlargement, is predictive of mortality under medical treatment and after mitral surgery in patients with organic MR due to flail leaflets. The relation between LA diameter and mortality was studied in 788 patients in sinus rhythm followed for 6.2±3.9 years. LA diameter was independently associated with survival after diagnosis (HR, 1.08 [1.04 to 1.12] per 1-mm increment). The optimal cutoff value for prediction of mortality identified by receiver operating characteristic curve analysis was 55 mm. LA diameter ≥55 mm was associated with more than 3-fold increase in the risk of overall and cardiac mortality under medical treatment. The association of LA diameter ≥55 mm and mortality was consistent in subgroups of patients with MR and similar excess mortality was observed in asymptomatic and symptomatic patients. In patients who underwent mitral surgery, LA diameter ≥55 mm had no independent impact on postoperative outcome. The authors' findings show that LA diameter is a simple measurement that might improve risk stratification and decision making in chronic organic MR. LA diameter ≥55 mm is associated with increased mortality under medical treatment, independent of the presence of symptoms or left ventricular dysfunction.
In MR caused by flail leaflets, LA diameter ≥55 mm is associated with increased mortality under medical treatment, independent of the presence of symptoms or left ventricular dysfunction.
42
Diagnostic Value of Vena Contracta Area in the Quantification of Mitral Regurgitation Severity by Color Doppler 3D Echocardiography
Summary: The calculation of an effective regurgitant orifice area (ROA) by the proximal isovelocity surface area method (PISA) is the primary technique for quantification of mitral regurgitation (MR) by echocardiography. However, it requires flow and geometric (hemisphere) assumptions, which have limited its clinical application. The development of color Doppler 3D echocardiography offers the ability to directly measure the ROA by measuring the vena contracta area (VCA) as 3D-guided. However, there are no data on the ranges and cutoff values of VCA for MR grading. In this study, direct planimetry of the VCA by 3D echocardiography was compared against the American Society of Echocardiography-recommended 2D integrative method as a reference. This integrative method is widely used in clinical practice and is thus most relevant. There were significant differences in VCA among patients with different MR grades. VCA at a cutoff value of 0.41cm2 reliably differentiates severe from moderate MR. As compared with 3D VCA, the 2D PISA method underestimated MR in patients with functional MR. Multivariable regression analysis showed that functional MR as etiology was the predictor of underestimation of MR by the PISA method. Three-dimensional VCA provides a single, directly visualized, and reliable measurement of ROA, which classifies MR severity comparable to current clinical practice using the American Society of Echocardiography-recommended 2D integrative method. The 3D VCA method improves accuracy of MR grading compared with the 2D PISA method by eliminating geometric and flow assumptions, allowing for uniform clinical grading cutoffs and ranges that apply regardless of etiology and orifice shape.
Conclusions: Three-dimensional VCA provides a single, directly visualized, and reliable measurement of ROA, which classifies MR severity comparable to current clinical practice using the American Society of Echocardiography-recommended 2D integrative method. The 3D VCA method improves accuracy of MR grading compared with the 2D PISA method by eliminating geometric and flow assumptions, allowing for uniform clinical grading cutoffs and ranges that apply regardless of etiology and orifice shape.
43
Evaluation of the Left Atrial Appendage With Real-Time 3-Dimensional Transesophageal Echocardiography: Implications for CatheterBased Left Atrial Appendage Closure
Summary: Precise knowledge of left atrial appendage (LAA) orifice size is crucial for correct sizing of LAA closure devices. Commonly, assessment of LAA orifice size is performed using 2D transesophageal echocardiography (2DTEE); however, 2DTEE has some limitations, inherent to its 2D nature. In the present study, the performance of realtime 3D transesophageal echocardiography (RT3DTEE) for LAA orifice size assessment, compared with 2DTEE, was evaluated and the impact of atrial fibrillation (AF) on LAA orifice size was investigated.
As compared with computed tomography, which was used as reference technique, RT3DTEE was found to be more accurate than 2DTEE for the assessment of LAA orifice size. Accordingly, RT3DTEE should be preferred to 2DTEE for the sizing of LAA closure devices. Regarding the impact of AF on LAA orifice, LAA orifice has been observed to be oval-shaped in control subjects and paroxysmal AF patients and to become larger and more round-shaped with increasing frequency of AF (ie, from paroxysmal to permanent form). Considering that all available occluders have a round shape, a round implant over an oval-shaped orifice (usually observed in paroxysmal AF patients) may lead to incomplete sealing of the orifice and to residual leaks. In addition, on the basis of the prespecified anatomic LAA requirements of available occluders, some persistent or permanent AF patients may not qualify for percutaneous LAA closure, due to an oversized LAA orifice. These observations suggest that further technological improvement is needed to ensure complete LAA sealing and to prevent device leak because of shape or eccentricity issues.
Conclusions: RT3DTEE is more accurate than 2DTEE for the assessment of LAA orifice size. A progressive increase in LAA orifice area is observed with increasing frequency of AF. successful CA. Similarly, right atrium (RA) remodeling has also been reported in AF patients but has not been focused on as a risk factor for AF recurrence. In the authors' study of 65 patients with paroxysmal AF, they observed similar structural and electric remodeling in both atria and demonstrate that both LA and RA remodeling as measured by cardiac CT were equally associated with post-CA AF occurring over a 6-month period after the CA. An important feature of RA and LA remodeling is their propensity to coexist because one predisposes the heart to the other. More important, it is perceived that the combination of these conditions carries AF recurrence than either alone.
Conclusions: Both LA and RA remodeling are equally associated with post-CA AF recurrence.
45
Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping
Summary: The development of diffuse myocardial fibrosis has been identified as a crucial step in the progression of myocardial disease toward heart failure. Despite this knowledge, fibrotic burden of the heart is not a routine component of clinical decision making because noninvasive quantification of diffuse myocardial fibrosis has not been routinely possible. Extracellular volume (ECV) can be determined by the use of T1 mapping magnetic resonance imaging (MRI) and has been proposed as a marker for collagen content of the myocardium. During the past few years, robust T1 mapping techniques for human applications have become available for most MRI systems.
Initial clinical studies showed promising results, suggesting the clinical potential of this approach. The results of the study on ECV changes in a small-animal model of mild angiotensin-2-induced diffuse myocardial fibrosis further support the validity of this concept, demonstrating significant increases of ECV in rats subjected to a 2-week infusion of angiotensin 2. There was a moderate correlation of ECV and collagen volume fraction, as assessed by histological analysis. The MRI-derived ECV can be noninvasively estimated in both humans and rodents, supporting serial in vivo studies of fibrosis in suitable preclinical models of disease to test novel therapeutic strategies that can be translated to clinical evaluation.
Conclusions:
In a small-animal model of left ventricular hypertrophy, contrast-enhanced T1 mapping can be used to detect diffuse myocardial fibrosis by quantification of myocardial ECV.
46
PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension
Summary: This is a comprehensive study in patients with idiopathic pulmonary arterial hypertension (New York Heart Association functional class I/II). All the patients underwent MRI, right heart catheterization, quantification of myocardial blood flow, quantification of myocardial glucose uptake, and cardiopulmonary exercise testing. The study revealed that PET scanning with 13N-NH3 and 18F-fluorodeoxyglucose appears to be a feasible modality for quantifying right ventricular (RV) blood flow and RV metabolism in patients with idiopathic pulmonary hypertension. An increased metabolic rate of glucose uptake in the RV presumably indicates early RV functional impairment. The shift in myocardial glucose uptake may be an early marker of RV dysfunction and possibly a preclinical marker before overt RV failure given that RV function on MRI in the current study was largely preserved and that most patients were in New York Heart Association functional class I/ II. The relations observed support the need for further investigation of myocardial glucose uptake as a novel early biomarker that could be a therapeutic target in the treatment and monitoring of pulmonary arterial hypertension. In addition, the study demonstrates a trend toward negative correlation with maximum oxygen consumption, suggesting that this finding may have some prognostic impact. Maximum oxygen consumption is considered a strong predictor of survival in patients with pulmonary arterial hypertension. Monitoring myocardial glucose uptake level may help to optimize treatment to improve function and outcome.
Conclusions: PET scanning with 13N-NH3 and 18F-fluorodeoxyglucose is a feasible modality for quantifying RV blood flow and metabolism in patients with idiopathic PAH.
47
Failure to Unmask Pseudonormal Diastolic Function by a Valsalva Maneuver: Tricuspid Insufficiency is a Major Factor
Summary: Advanced diastolic dysfunction is often related to dyspnea. For the clinical assessment of patients with dyspnea, the echocardiographic inversion of the early (E) and late (A) transmitral flow during Valsalva maneuver (VM) frequently helps to distinguish pseudonormal (advanced diastolic dysfunction) from normal filling pattern. The authors' study showed that the absence of an E/A inversion after VM is not necessary indicative of normal diastolic filling. Furthermore, the current data demonstrate that significant tricuspid insufficiency might be the reason for the failed response to VM in patients with a pseudonormal diastolic dysfunction. Thus, in these patients with significant tricuspid insufficiency, other established parameters should be taken into account when evaluating diastolic function. This study reinforces the observation that no single parameter can be used to assess diastolic function and that changes in loading conditions and heart rate frequently affect diastolic function indices.
Conclusions:
The authors' data suggest that TI is a major factor to prevent E/A inversion during a VM in patients with pseudonormal diastolic function. This probably is due to a decrease in TI resulting in an increase in forward flow rather than the expected decrease during the VM. Thus, whenever a pseudonormal diastolic filling pattern is suspected, the use of a VM is not an informative discriminator in the presence of moderate or severe TI.
48
Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy
Summary: Myocardial dysfunction is common in apparently well subjects with type 2 diabetes mellitus. Myocardial fibrosis is increasingly recognized as a potential contributor to this process and has plausible connections with hyperglycemia and other metabolic factors. Noninvasive identification of myocardial fibrosis is challenging, because endomyocardial biopsy cannot be justified in asymptomatic subjects. Recently, cardiac magnetic resonance T1 mapping techniques have been developed to enable quantification of diffuse fibrosis. Other imaging parameters such as backscatter and tissue Doppler imaging (tissue velocity, strain, and strain rate) are useful in identifying subclinical myocardial structural and functional abnormalities that may be related to underlying fibrosis. Myocardial collagen turnover can also be estimated noninvasively by measuring procollagen biomarker levels in peripheral blood. The authors hypothesized that a relationship could be established between these noninvasive markers of myocardial fibrosis and metabolic control in type 2 diabetes mellitus. This would support fibrosis as an underling mechanism for myocardial dysfunction and suggest that metabolic derangement is a predisposing factor. In a multimodality study of 67 subjects with type 2 diabetes mellitus, T1 values on cardiac magnetic resonance were compared with echocardiographic parameters of subclinical diabetic heart disease, procollagen biomarker levels, and metabolic control.
Conclusions:
The association between myocardial diastolic dysfunction, postcontrast T1 values, and metabolic disturbance supports that diffuse myocardial fibrosis is an underlying contributor to early diabetic cardiomyopathy.
49
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Left Atrial Remodeling and Response to Valsartan in the Prevention of Recurrent Atrial Fibrillation: The GISSI-AF Echocardiographic Substudy
Summary: Atrial fibrillation (AF) imposes a symptomatic burden and the risk of cardiovascular events that increase in frequency with the progression of atrial electric and structural remodeling. The hypothesis that long-term renin-angiotensin system inhibition could reverse left atrial (LA) remodeling and thereby favor the prevention of AF recurrence was tested in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. The results revealed a neutral effect of valsartan treatment for 1 year on AF recurrence. The echocardiographic substudy results were consistent with those of the main study by showing valsartan to have no effect on LA volume. Severe LA enlargement (≥40 mL/m2) recorded in 55% of the patients with only minimal increase in LV wall thickness and Doppler E/e′ argues for the arrhythmia itself as the main cause of LA remodeling. Additionally, in the patients without AF recurrence in 1 year, LA maximal volume was equally and severely dilated; therefore, mechanisms other than remodeling need consideration in future studies. Although LA maximal volume was not predictive of first recurrence of AF, in patients with recurrent AF (54%), larger LA volumes and lower LA emptying fraction did forecast longer episodes of AF recurrence. The entry of 85% hypertensive patients and only 10% with left ventricular dysfunction and heart failure emphasizes the causal role of blood pressure in AF. Aggressive treatment of blood pressure targeted to increasing LA volumes could slow and possibly halt progressive LA remodeling and prevent or reduce the burden of recurrent AF.
Conclusions: GISSI-AF patients in sinus rhythm and history of AF showed severely increased LAVmax with mostly normal LV volume, mass, and systolic and diastolic function. Valsartan for 1 year did not reverse LA remodeling or prevent AFr. Half of the patients without AFr had severe LA dilation; therefore, mechanisms other than structural remodeling triggered recurrence.
50
Quantitative Assessment of Artifacts on Cardiac Magnetic Resonance Imaging of Patients With Pacemakers and Implantable Cardioverter-Defibrillators
Summary: The decision to perform cardiac magnetic resonance (CMR) imaging in patients with cardiac pacemakers (PMs) and implantable cardioverter-defibrillator (ICDs) depends on the balance of risks versus benefits of imaging in each individual. Although considerable work has focused on safety considerations, this work evaluated the potential limitations imposed on CMR by susceptibility artifacts in patients with PM/ICDs. In patients with left-sided PM and right-sided PM/ICD systems, CMR images had minimal artifacts regardless of the image sequence and were completely interpretable. In contrast, in patients with left-sided ICD/biventricular (BiV)-ICD systems, artifact effects on late gadolinium-enhanced (LGE)-CMR were greater than those on MR angiography, cine, T2-weighted, and perfusion CMR. The authors found it particularly difficult to evaluate the anterior and apical regions on LGE-CMR of patients with leftsided ICD/BiV-ICD systems. Lower body mass index, larger generator size, larger left ventricular end-diastolic diameter, and shorter distance between the PM/ICD generator and the cardiac silhouette on chest radiography are associated with greater artifact size on CMR.
The results of this study may improve patient selection for CMR in the setting of PM/ICD systems.
Conclusions:
In contrast to patients with right-sided PM/ICD and leftsided PM, the anterior and apical left ventricle can be affected by susceptibility artifacts in patients with left-sided ICD. Artifact reduction methodologies will be necessary to improve the performance of CMR in patients with left sided ICD systems. Summary: Among 427 participants with and without lower-extremity peripheral arterial disease (PAD), the authors found that lower anklebrachial index values were associated with greater atherosclerotic plaque and smaller lumen area in the proximal segment of the superficial femoral artery (SFA). Associations remained in the subset of participants with PAD and were independent of age, sex, race, and atherosclerotic disease risk factors. PAD participants who had no exertional leg symptoms (that is, were asymptomatic) had less atherosclerotic plaque and a larger lumen area in the proximal region of the SFA. These findings suggest that SFA plaque and lumen area in the initial segment of the SFA may be surrogates for atherosclerotic disease burden in the lower extremities as measured by the anklebrachial index.
Lower ABI values are associated with greater MRImeasured plaque burden and smaller lumen area in the first 30 mm of the SFA. Compared with PAD participants with claudication, asymptomatic PAD participants have smaller plaque area and larger lumen area in the SFA.
52
Abdominal Aortic Aneurysm Growth Predicted by Uptake of Ultrasmall Superparamagnetic Particles of Iron Oxide: A Pilot Study
Summary: Abdominal aortic aneurysm (AAA) rupture is a catastrophic event associated with a very high mortality rate. Patients with known AAA are therefore enrolled in a surveillance program involving serial ultrasound scanning to monitor changes in aneurysm diameter, taken as a surrogate for risk of rupture. Patients with an aneurysm >5.5 cm in diameter are perceived to be at high risk and are offered surgical or endovascular aneurysm repair. Although AAA diameter is the best predictor of rupture currently available, up to 20% of ruptured AAA are <5.5 cm. Large studies have shown no mortality benefit for early surgery over continued surveillance in this group of patients. Conversely, many patients have AAA considerably larger than 5.5 cm without rupture. The authors therefore need an improved method of predicting rupture for individual patients. Rupture is thought to occur in regions of the aortic wall featuring intense inflammation and proteolytic activity. The authors used MRI with a novel contrast agent consisting of ultrasmall superparamagnetic particles of iron oxide (USPIO) to identify focal inflammation within the aortic wall. The key finding is that USPIO uptake within the aortic wall was associated with a rate of aneurysm expansion (0.66 cm/y) 3-fold higher than AAA with no mural USPIO uptake. If confirmed in larger longitudinal studies, these results suggest that USPIO-enhanced MRI may be a more accurate way to predict disease progression than diameter alone in patients with AAA, facilitating selection of patients for preventative surgery.
Conclusions: Uptake of USPIO in abdominal aortic aneurysms identifies cellular inflammation and appears to distinguish those patients with more rapidly progressive abdominal aortic aneurysm expansion. This technique holds major promise as a new method of risk-stratifying patients with abdominal aortic aneurysms that extends beyond the simple anatomic measure of aneurysm diameter.
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Noninvasive Vascular Function Measurement in The Community: Cross-Sectional Relations and Comparison of Method
Summary: Over the past years, several noninvasive measurement methods of vascular structure and reactivity have been implemented to assess cardiovascular function. The authors simultaneously measured flow-mediated dilation of the brachial artery, which reflects large artery reactivity, and finger pulse amplitude through volume and infrared plethysmography to assess microvascular function at baseline and after a 5-minute upper-arm occlusion in a populationbased cohort. Vascular function measures showed low correlations among one another. The cardiovascular risk factors associated strongly with the most vascular function measures were age and sex followed by body mass index and indicators of blood pressure. Whereas baseline parameters were correlated with a broad spectrum of cardiovascular risk factors, the correlation with hyperemic response variables was weaker, and the overall variability explained by the risk factors was lower (maximum 15.4% for flow-mediated dilation). To understand the association of the 3 methods with cardiovascular disease outcomes, prospective data are needed to evaluate the value of structural and dynamic arterial changes for risk screening beyond classical risk factors.
Conclusions: Noninvasive measures of conduit artery and peripheral arterial function are modestly correlated, differ in their relation to classical cardiovascular risk factors, and may thus reflect different pathologies.
54
Identification of Coronary Plaque Sub-Types Using Virtual Histology Intravascular Ultrasound Is Affected by Inter-Observer Variability and Differences in Plaque Definitions
Summary: Virtual histology intravascular ultrasound (VH-IVUS) is being used increasingly to study the natural history of atherosclerosis and the effect of interventions. VH-IVUS-based plaque classification has been shown to provide important prognostic information on the natural history of individual plaques, raising the prospect that VH-thin cap fibroatheroma (VH-TCFA) identification at the time of intervention can direct immediate treatment. However, VH-IVUS plaque classification depends critically on subjective assessments of plaque morphology. Thus, knowledge about variation between local observers, for example as compared with a central read in a core laboratory, which may use additional software to ensure consistency in large VH-IVUS trials, is important. Finally, variations in plaque definitions among different studies may alter VH-TCFA frequency. The authors show that while VH-IVUS agreement between trained observers in a single-center is excellent, VH-TCFA detection is highly variable between single-center observers. The agreement was weakened further if border correction and plaque classification was performed by 2 different centers. Different plaque definitions also impacted on the prevalence of VH-IVUS-defined TCFA and the diagnostic accuracy of gray scale-IVUS to identify TCFA was poor. VH-IVUS inter-observer variability needs to be taken into account when analyzing studies that pool data from multiple centers without a central core laboratory assessment.
Conclusions: VH-IVUS plaque classification, and particularly VH-IVUS-defined thin-capped fibroatheromata identification, varies significantly between local observers, and particularly in comparison with core-laboratory analysis. Differences in VH-IVUS plaque definitions introduce further variability between studies. These factors reduce the use of VH-IVUS plaque classification to guide intervention in a "live" clinical setting, and also affect comparison of diagnostic accuracy and natural history of plaques between studies.
55
Provider-Directed Imaging Stress Testing Reduces Health Care Expenditures in Lower-Risk Chest Pain Patients Presenting to the Emergency Department
Summary: In an effort to define a more efficient and efficacious care pathway for patients with chest pain treated in an observation unit, the authors examined the role of a mandatory cardiac magnetic resonance (CMR) stress imaging pathway in lower-risk emergency department patients with symptoms of acute coronary syndrome. In comparison to a mandatory CMR pathway, participants in a care pathway in which care providers chose the stress imaging modality (with an option for CMR) had decreased cost, similar lengths of stay, and similar clinical outcomes. The results of this randomized trial suggest that preserving the physician choice in selecting a stress modality is an important component to efficient care delivery in patients with lower-risk symptoms of acute coronary syndrome being treated in an emergency department-directed observation unit. These findings are in contrast to prior findings in patients at intermediate to high risk, in whom an observation unit strategy with stress CMR is a cost-effective alternative to inpatient care. The health policy implication of this research is that before instituting a mandate for a particular imaging modality, prospective studies to evaluate the impact on efficiency and cost should be performed.
Conclusions:
In patients with lower-risk chest pain receiving emergency department-directed OU care, the ability of a physician to select a cardiac stress imaging modality (including echocardiography, CMR, or radionuclide testing) was more cost-effective than a pathway that mandates a CMR stress test. Contrary to prior observations in individuals with intermediate-to high-risk chest pain, in those with lower-risk chest pain, these results highlight the importance of physician-related choices during acute coronary syndrome diagnostic protocols.
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In Vivo Assessment of Ergonovine-Induced Coronary Artery Spasm by 64-Slice Multislice Computed Tomography
Summary: Coronary artery spasm has been shown to play an important role in the pathogenesis of not only vasospastic angina, but also many types of ischemic heart disease. Provocation testing is the clinically available procedure used in the diagnosis of definite coronary spasm, but it is invasive and sometimes becomes dangerous. Advances in multislice CT (MSCT) image technology have enabled evaluation of coronary artery stenosis and coronary plaque components. As such, prediction of epicardial coronary artery spasm by MSCT should be useful in clinical practice. Unfortunately, the current generation of MSCT cannot assess endothelial function associated with epicardial coronary artery, but this study demonstrates that MSCT might be useful in predicting epicardial coronary spasm by evaluating the morphological features of the vascular wall.
Conclusions: MSCT can detect differences in individual plaque composition and morphology among atherosclerotic plaques without significant luminal narrowing in areas of inducible vasospasm compared to areas without vasospasm.
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Regional Coronary Endothelial Function is Closely Related to Local Early Coronary Atherosclerosis in Patients With Mild Coronary Artery Disease: Pilot Study
Summary: This study demonstrates, for the first time, (1) that abnormal coronary endothelial function and increased coronary wall thickness can be detected during a single, noninvasive 3-T MRI examination; and (2) that abnormal coronary endothelial-dependent vasoreactivity is present locally in mildly diseased coronaries and related to
The Editors Editors' Pick: Most Important Articles in Cardiovascular Imaging Science, Part II e45 the earliest noninvasive in vivo measure of local coronary atherosclerosis, an increase in coronary artery wall thickness. Thus, in a given coronary artery segment, early anatomic markers of coronary atherosclerosis are closely linked to functional markers in that segment that may occur long before the development of severe stenotic disease. The ability to noninvasively and without contrast evaluate both structural subclinical atherosclerosis and coronary endothelial function provides an opportunity to evaluate both aspects of the coronary response to therapeutic intervention. This may also contribute to improved detection and monitoring of atherosclerotic disease and its response to therapy at an early, preclinical stage as well as the ability to noninvasively investigate anatomic and functional predictors of disease progression.
Conclusions:
There is an inverse relationship between coronary endothelial function and local coronary wall thickness in patients with coronary artery disease but not in healthy adults. These findings demonstrate that local endothelial-dependent functional changes are related to the extent of early anatomic atherosclerosis in mildly diseased arteries. This combined MRI approach enables the anatomic and functional investigation of early coronary disease.
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Myocardial Perfusion Reserve Assessed by T2-Prepared Steady-State Free Precession Blood Oxygen Level-Dependent Magnetic Resonance Imaging in Comparison to Fractional Flow Reserve
Summary: T2-prepared steady-state free precession blood oxygen level-dependent cardiac magnetic resonance imaging is based on different magnetic properties of oxyhemoglobin and deoxyhemoglobin. This results in a relative decrease of T2* and T2 relaxation time in ischemic and thus lower oxygenated myocardium. In their study, the authors demonstrate that this effect correlates to invasively measured fractional flow reserve in the respective coronary artery. The authors' described approach warrants consideration as an alternative to contrast-enhanced perfusion studies, especially in patients with severe renal failure in which the use of exogenous contrast agents should be avoided.
Conclusions: CMR BOLD imaging reliably detects hemodynamic significant coronary artery disease and is, thus, an alternative to contrast-enhanced perfusion studies.
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Aligning Coronary Anatomy and Myocardial Perfusion Territories: An Algorithm for the CORE320 Multicenter Study
Summary: Myocardial perfusion analysis is a relatively new computed tomography application that can add physiological information to a well-established anatomical method. It may have its greatest relevance in situations where intermediate lesions or heavily calcified coronary stenosis are detected on the computed tomography angiography and perfusion data would orient a better clinical decision, regarding revascularization or clinical treatment. To achieve clinical application, it still needs validation against established diagnostic methods, where the combination of anatomical and physiological data can be challenging. The proposed vascular territory model introduces the coronary anatomy variability in a standardized fashion, assuring accuracy of the alignment using different imaging modalities. These features are extremely important, especially for research purposes, because they permit a more reliable comparison between modalities that may also be used clinically in the future.
Conclusions:
The authors present a vascular territory distribution model developed for the CORE320 multicenter study, which accounts for variability in coronary anatomy and potential myocardial perfusion territory overlap.
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Cardiac Myosin Binding Protein C Insufficiency Leads to Early Onset of Mechanical Dysfunction
Summary: Hypertrophic cardiomyopathy (HCM) is a disease caused by mutations in genes that encode sarcomeric proteins. Mutations in cardiac myosin binding protein C (cMyBPC) are among the most common causes genetically explained HCM, accounting for more than 40% of the total known cases worldwide. A large number of disease-causing mutations in cMyBPC in humans are predicted to produce C-terminal truncated proteins that are not incorporated into the sarcomere, resulting in cMyBPC haploinsufficiency, which reduces the total amount of cMyBPC in the sarcomere. However, the link between decreased cMyBPC expression in the sarcomere and the development of cardiac disease is unclear. The authors' data demonstrate that a mouse model of cMyBPC haploinsufficiency with only 1 functional cMyBPC allele (cMyBPC+/−) displays a 24% reduction in total cMyBPC expression and accelerated cross-bridge kinetics, which underlies in vivo impairments in systolic and diastolic cardiac mechanics measured by MRI. Importantly, reduced mechanical indices of torsion, twist, and strain were apparent in young cMyBPC+/− mice 8-10 weeks of age, suggesting that cardiac dysfunction in cMyBPC-related HCM is not necessarily late-onset, as is commonly accepted, but may be detected early in life using high-resolution cardiac MRI. Furthermore, in contrast to the severe mechanical dysfunction and cardiac hypertrophy displayed by cMyBPC-null mice, mechanical dysfunction in cMyBPC+/− mice was apparent before the development of overt cardiac hypertrophy, implicating altered mechanical function as the first link between reduced cMyBPC expression in the sarcomere and the development of pathological hypertrophy and cardiac disease.
Conclusions: Modest decreases in cMyBPC expression in the mouse heart result in early-onset subtle changes in cross-bridge kinetics and in vivo LV mechanical function, which could contribute to the development of HCM later in life.
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A New Method for Cardiac Computed Tomography Regional Function Assessment: Stretch Quantifier for Endocardial Engraved Zones (SQUEEZ)
Summary: Determination of left ventricular regional function is important in the diagnosis and management of cardiomyopathy. The authors describe a novel, CT-based method, SQUEEZ (Stretch Quantifier for Endocardial Engraved Zones), that provides highly quantitative measures of regional myocardial function and can distinguish between infarcted and normally contracting myocardial regions with minimal user interaction and high resolution. This approach may have particular clinical value in assessing patients with dyssynchronous heart failure to better identify their candidacy for cardiac resynchronization therapy and may help to guide cardiac resynchronization therapy lead placement to the most appropriate myocardial location. Additionally, SQUEEZ may help to assess myocardial dysfunction in patients with myocardial ischemia, especially when used in tandem with CT coronary atherosclerosis and emerging CT regional blood flow assessment techniques.
Conclusions:
The authors present a new quantitative method for measuring regional cardiac function from high-resolution volumetric CT images, which can be acquired during angiography and myocardial perfusion scans. Quantified measures of regional cardiac mechanics in normal and abnormally contracting regions in infarcted hearts were shown to correspond well with noninfarcted and infarcted regions as detected by delayed enhancement cardiovascular magnetic resonance images. 
Prognostic Value of Right Ventricular Longitudinal Peak Systolic Strain in Patients With Pulmonary Hypertension
Summary: Right ventricular (RV) function is an important prognostic factor in patients with pulmonary hypertension. Therefore, timely and accurate detection of RV dysfunction is of clinical importance. However, RV function assessment is challenging with conventional 2-dimensional echocardiography. The advent of 2-dimensional speckle-tracking echocardiography has permitted to accurately assess active myocardial contraction and overcome the limitations of conventional 2-dimensional parameters of RV function. In 150 patients with pulmonary hypertension of different causes, RV longitudinal strain assessed with 2-dimensional speckle tracking was independently associated with survival, after adjusting for age, New York Heart Association functional class, left ventricular ejection fraction, and systolic pulmonary arterial pressure. Patients with pulmonary hypertension and RV longitudinal strain greater than or equal to −19% had more than 3 fold risk of death compared with their counterparts with RV longitudinal strain less than −19%. RV longitudinal strain may be a valuable parameter for risk stratification of patients with pulmonary hypertension. Future studies are needed to confirm these results in the pulmonary hypertension subgroups.
Conclusions:
In patients with pulmonary hypertension, RV LPSS is significantly associated with all-cause mortality. RV LPSS may be a valuable parameter for risk stratification of these patients. Future studies are needed to confirm these results in the pulmonary hypertension subgroups.
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Differentiation Between Fresh and Old Left Ventricular Thrombi by Deformation Imaging
Summary: Left ventricular thrombi after myocardial infarction are linked with a risk of systemic embolization. The majority of these events occur within the initial 4 months after myocardial infarction. Thus, the ability to differentiate between old and fresh left ventricular thrombi is of clinical importance. This study applied the technique of echocardiographic myocardial deformation imaging to the analysis of left ventricular thrombi. The 2-part study proposes an echocardiographic method to reliably differentiate fresh from old intracavitary thrombi, easy to implement in everyday routine. In this prospective study, sufficient anticoagulation not only diminished the risk of systemic embolization-a well-known fact-but also resulted in fresh thrombus resolution, whereas in patients with old thrombi, anticoagulation had no effect on thrombus resolution. This study has potentially significant clinical implications that should be explored in a larger, prospective study. Such a study might provide new insights concerning the identification of patients with fresh left ventricular thrombus in whom unfavorable consequences might be more likely and who therefore might benefit from anticoagulation.
Conclusions: Fresh and old intracavitary thrombi can be reliably differentiated by deformation imaging. In fresh thrombi, anticoagulation with phenprocoumon results in thrombus resolution in most patients.
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Subclinical Left Ventricular Dysfunction in Preeclamptic Women With Preserved Left Ventricular Ejection Fraction: A 2D SpeckleTracking Imaging Study
Summary: Patients with preeclampsia are at an increased risk of cardiovascular disease, which has been associated with long-term postpartum morbidity and mortality. Ejection fraction remains relatively preserved until late in the course of the disease. Measurement of strain using speckle echocardiography is being increasingly used to detect subclinical myocardial dysfunction. In this study, the authors show that women with preeclampsia have subclinical myocardial dysfunction as demonstrated by a decreased global longitudinal, radial, and circumferential strain in the setting of preserved ejection fraction. The authors' data are a step toward early detection of myocardial dysfunction in preeclampsia.
Conclusions: Myocardial strain imaging using speckle tracking is more sensitive than left ventricular ejection fraction to detect differences in left ventricular systolic function in women with and without preeclampsia. Overall, strain measured by VVI was more variable than MRI and the limits of agreement were slightly, but not significantly, closer for global CS than RS. Both VVI and MRI strain measurements showed significantly lower global CS strain in the knockout groups compared with the wild-type, but only the VVI CS strain measurements were different between the 2 knockout groups. These data demonstrate that measurements of LV CS and RS are feasible in mice using VVI, although correlations and agreement were modest. VVI may complement conventional methods that objectively assess global and regional LV function and be particularly useful for high through-put phenotyping of murine models.
Conclusions: Measurements of left ventricular CS and RS are feasible in small animals using 2-dimensional echocardiography. VVI and MRI strain measurements correlated modestly and the agreement between the modalities tended to be greater for CS than RS. Although VVI and MRI strains were able to differentiate between wild-type and knockout mice, only global CS VVI differentiated between the 2 models of cardiomyopathy. Summary: Obesity is a major health concern worldwide. Left ventricular (LV) dysfunction and heart failure are the most serious complications, contributing to obesity's increasing morbidity and mortality. Despite the World Health Organization's definition of obesity as an excessive fat accumulation, body mass index (BMI) estimation has become a dominant approach in the identification of obese subjects. However, because the adverse effects of adiposity on the circulatory system are strictly associated with the biological milieu provided by fat tissue including the release of cardioinhibitory cytokines and fibrosis mediators and the promotion of insulin resistance, increased fat deposition might predispose to cardiac derangements even at a low BMI. In view of this, the authors hypothesized that cardiac function in patients with a normal BMI but elevated body fat content (normal-weight 
Increasing Plasma Free Fatty Acids in Healthy Subjects Induces Aortic Distensibility Changes Seen in Obesity
Summary: Obesity is associated with increased mortality and is now a well-recognized risk factor for cardiovascular disease, exerting independent adverse effects on the cardiovascular system. Because obesity is associated with increased arterial stiffness, an independent predictor of mortality, this has become 1 of the candidate mechanisms to explain at least part of the increased mortality seen in obesity. Despite the well-documented link between obesity and vascular stiffness, the mechanisms by which obesity modulates vascular function are not well understood. Insulin-resistant states such as obesity are characterized by elevated plasma free fatty acid levels, which have been shown to be associated with a greater risk of developing impaired glucose tolerance and Type 2 diabetes. In this study, the authors not only demonstrate a relationship between aortic distensibility and free fatty acid in obesity, but also that acute elevation of free fatty acid in normal-weight individuals free of cardiovascular disease induces insulin resistance and reduces aortic distensibility within 4 hours in a pattern similar to that seen in obesity. Furthermore, the authors have shown that dietary elevation of free fatty acid also reduces aortic distensibility, again in a similar pattern to obesity. These findings demonstrate elevated free fatty acids as a mechanism that is likely to contribute to the reduction in aortic distensibility in obesity and open the possibility of elevated free fatty acid as a potential therapeutic target to improve vascular function in obesity, which, given its relationship with cardiovascular mortality, has wide-reaching clinical implications.
Conclusions: Both intralipid infusion and a low-carbohydrate diet resulted in reduced abdominal AD (infusion −22%, diet −28%; both P<0.05), reproducing the distal pattern AD reduction seen in obesity. These findings suggest that elevated FFA impair AD in obesity and provide a potential therapeutic target to improve aortic elastic function in obesity.
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Effects of Hemodynamics on Global and Regional Lung Perfusion: A Quantitative Lung Perfusion Study by Magnetic Resonance Imaging
Summary: Using lung perfusion quantification by magnetic resonance imaging, the authors demonstrated the complex association of lung perfusion with cardiac output and hemodynamics. Although absolute global and regional lung perfusion were determined mainly by cardiac output, regional perfusion distribution was affected by hemodynamic abnormalities, predominantly elevated left ventricular end-diastolic pressure and resultant increases in mean pulmonary artery pressure. Among those with significantly elevated left ventricular end-diastolic pressure, there was near equalization of lung perfusion from anterior to posterior lung fields in the supine position, abolishing the normal gravitational lung perfusion gradient. Multivariate regression analysis suggested that mean pulmonary artery pressure was the most important determinant of altered perfusion distribution among all the hemodynamic indices, underscoring the importance of the pulmonary arterial response to left ventricular end-diastolic pressure and not simply left ventricular end-diastolic pressure alone in the pathophysiology of left heart failure.
Conclusions: Increased left ventricular filling pressure and the resultant increase in pulmonary arterial pressure are associated with disruption of the normal gravitational lung perfusion gradient. The authors' findings underscore the complexity of heart-lung interaction in determining pulmonary hemodynamics in left heart failure.
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A Simple Echocardiographic Prediction Rule for Hemodynamics in Pulmonary Hypertension
Summary: This article describes a simple echocardiographic prediction rule to define the hemodynamic physiology of pulmonary hypertension (PH). The score uses ubiquitously acquired echocardiographic data (LA size, lateral mitral E:e′, and pulse wave Doppler of the right ventricular outflow tract) to predict the likelihood that a given patient has PH attributed to pulmonary vascular disease (PHPVD: normal left heart filling pressure and elevated PVR) or whether the PH is more likely related to left heart disease with elevated left atrial pressure. A positive score is highly suggestive of PHPVD physiology, and strongly argues for invasive hemodynamic investigation with anticipation of pulmonary vascular disease, even in the absence of elevated Doppler-estimated pulmonary artery systolic pressure. A negative score essentially excludes PHPVD physiology and should prompt further investigation and treatment of left heart disease. The simplicity and practicality of this prediction rule, coupled with impressive test characteristics, will facilitate widespread clinical application.
Conclusions:
The authors present a simple echocardiographic prediction rule that accurately defines PH hemodynamics, facilitates improved screening and focused clinical investigation for PH diagnosis and management. In the study, the authors derived and validated an allometric model for children with BSA ≤1 m2 and >1 m2. The allometric models were further validated in a prospective cohort of children with structurally normal hearts and BSA. Indexing chamber volumes using BSA to the exponent of 1 is physiologically incorrect, and this has been published previously for left ventricular volumes. Results of the analysis show that z scores for indexed LAV should be based on indexing LAV/BSA1.48 and LAV/BSA1.08 in children with BSA ≤1 m2 and >1 m2, respectively. Using the validated allometric model will allow for accurate diagnosis of left atrial enlargement that will be independent of patients' body size, age, and sex. The z-score graphs provided will allow for referencing and allocation of z scores for measured LAV. CRT even in the presence of myocardial scar, suggest that mechanical discoordination rather than dyssynchrony should be assessed for prediction of CRT response. Future studies should focus on improving ease of measurement of mechanical discoordination to establish widespread clinical application in the diagnostic workup of CRT candidates. In the future, a deliberate selection of mechanical discoordination indices may serve as input for an integrative patient-specific computer model to improve patient selection and effectiveness of CRT.
Mechanistic Evaluation of Echocardiographic
Conclusions:
The power to predict CRT response differs between indices of mechanical dyssynchrony. SRSsept and IVMD better represent LV dyssynchrony amenable to CRT and better predict CRT response than the indices assessing time-to-peak deformation or motion. Summary: Stroke remains a leading cause of morbidity and mortality worldwide. More than 80% are ischemic in nature; about 65-70% are triggered by sudden rupture of atherosclerotic plaques. Although current diagnostic and therapeutic guidelines, which rely on vessel narrowing, have shown clear benefits in symptomatic patients with severe stenosis (>69% narrowing), clinical decision-making based on stenosis severity is not as clear in patients with symptomatic moderate or asymptomatic carotid disease. The results of the study provide evidence that multimodality imaging with positron emission tomography and computed tomography provides complementary information about highrisk morphological features and inflammation. Given the importance of both morphology and inflammation to subsequent atherothrombosis, it is possible that the combination of structure and inflammatory imaging data may produce information that can improve clinical decisionmaking, a hypothesis that needs prospective evaluation.
Conclusions: Inflammation, as assessed by both FDG uptake and histology, is increased in plaques containing HRM and increases with increasing number of HRM. These data support the concept that inflammation accumulates relative to the burden of morphological abnormalities.
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Molecular Imaging of Mesenchymal Stem Cell: Mechanistic Insight into Cardiac Repair After Experimental Myocardial Infarction
Summary: Adult stem cells have been used to treat heart diseases for over a decade. Preclinical studies have demonstrated that mesenchymal stem cells (MSCs) facilitate both myocardial repair and neovascularization in animal models of cardiac injury. Human clinical trials have also validated the safety of MSC therapy in patients with acute myocardial infarction and heart failure. However, the mechanisms whereby MSCs exert their beneficial effect in improving cardiac function is not precisely known. Here, the authors used molecular imaging to track the fate of MSCs following their injection into the peri-infarct regions of the heart. The authors showed that human MSCs can develop into endothelial-like cells, but not cardiomyocytes. However, these injected cells disappeared completely from the heart in two months. Interestingly, the improvement in cardiac function as measured by changes in ejection fraction persisted for up to 6 months. The authors also found that injection of MSCs into the heart enhanced the development of new blood vessels and decreased cardiac fibrosis following myocardial infarction. In conclusion, the beneficial effects extended by the MSCs are mediated by a paracrine effect, through factors secreted by the MSCs. Thus, the animal model provided insights into the potential mechanisms whereby MSCs help to repair the heart after myocardial infarction.
Conclusions: hMSCs differentiated into endothelial cells and integrated into blood vessels after experimental myocardial infarction. The differentiated hMSCs only lasted for up to 50 days in vivo, but improvement in cardiac function persisted for up to 6 months. Increased angiogenesis and decreased fibrosis were associated with cardiac functional improvement after hMSC transplantation. Interventions to increase BAT volume and activation are being extensively investigated as therapies to decrease the body weight in obese subjects. The objective of this study was to validate contrast ultrasound (CU) as a method to noninvasively estimate BAT blood flow in mice. The authors' findings suggest that CU can not only detect BAT but also estimate increases in blood flow associated with BAT activation. CU could potentially be used in preclinical trials to measure the effect of antiobesity therapies that modulate BAT function. If translated to humans, CU could be performed serially in longitudinal studies of BAT-modulating therapies.
Conclusions:
These results indicate that CU can detect BAT in mice and estimate BAT blood flow in mice with functional differences in BAT.
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Predictors for Neoatherosclerosis: A Retrospective Observational Study From the Optical Coherence Tomography Registry
Summary: Very late stent thrombosis was first reported a decade ago and remains a concern even with the introduction of drugeluting stents. Neointima inside stents develops lipid-laden plaque, calcification, disruption, macrophage infiltration, and thrombosis, which is termed neoatherosclerosis. The true incidence, exact mechanisms, predictors, and treatment of this pathology are incompletely understood. This study reports predictors for the development of neoatherosclerosis. In addition to stent type (drug-eluting stent) and stent age (≥48 months), other modifiable predictors such as current smoking, chronic kidney disease, and usage of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker were identified. These predictors may help to understand underlying mechanisms leading to late stent thrombosis and may help develop strategies to prevent the development of neoatherosclerosis. If these findings are confirmed, subsequent studies can determine whether modifying these predictors can reduce the incidence of neoatherosclerosis.
Conclusions: In addition to the stent type and the stent age, patient characteristics, including current smoking, chronic kidney disease, and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockade, were associated with the presence of NA. This result may support the importance of secondary prevention after stent implantation.
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Utility of Cardiovascular Magnetic Resonance in Identifying Substrate for Malignant Ventricular Arrhythmias
Summary: Patients presenting with malignant ventricular arrhythmias outside of the setting of acute coronary syndrome pose a diagnostic and therapeutic challenge to the practicing clinician. One of the primary aims of cardiac imaging in this setting is the identification of underlying myocardial disease to offer plausible explanations for arrhythmia occurrence. However, the ability of diagnostic imaging to identify myocardial substrate for arrhythmia, the spectrum of such substrate that may be identified, and the incremental impact of these findings on diagnosis category are unknown. This study evaluated the diagnostic findings of routinely performed imaging other than cardiac magnetic resonance (CMR) versus comprehensive CMR to evaluate their respective diagnostic yield and impact on clinical diagnosis category in patients presenting with resuscitated sudden cardiac death (SCD) or sustained monomorphic ventricular tachycardia. In this population, a 50% increase in diagnostic yield of relevant myocardial disease was appreciated using CMR versus non-CMR imaging. This incremental yield translated into a new alternate diagnosis category being assigned in half of patients. For patients experiencing resuscitated SCD, approximately one third, by CMR, had unsuspected acute myocardial injury, offering identification of acute precipitants for otherwise unexplained cardiac arrest. In these patients, such findings may have important implications for therapeutic decision making and warrant further investigation. Overall, this study identifies that early CMR may be an efficient and highyield diagnostic approach for the evaluation of patients presenting with malignant ventricular arrhythmias.
Conclusions: CMR-based imaging provides a robust diagnostic yield in patients presenting with resuscitated SCD or SMVT and incrementally identifies clinically unsuspected acute myocardial injury. When compared with non-CMR-based imaging, a new or alternate myocardial disease process may be identified in half of these patients. Summary: In a multicenter study concerning low-flow low-gradient aortic stenosis (LFLG AS) despite normal ejection fraction, the role of speckle tracking echocardiography in detecting subtle left ventricular dysfunction is reported. In addition to elevated afterload, the severe longitudinal dysfunction documented by 2D strain in these patients gives a new explanation to the concept of LFLG AS. The main findings of the study are two fold. First, among patients with severe AS, low gradient, and normal LV ejection fraction, 2 different patterns can be observed, with different hemodynamic characteristics and aortic severity. LFLG AS is observed in 9% of patients and is associated with high global afterload and reduced longitudinal systolic function. Patients with NFLG AS are more frequent and present with less severe AS, normal afterload, and less severe longitudinal dysfunction. Second, in clinical practice, 2 parameters are of major importance in the evaluation of patients with low-gradient severe aortic stenosis despite normal ejection fraction. Valvulo-arterial impedance allows an evaluation of LV afterload. It is significantly elevated in LFLG AS, and has been shown to be an independent prognostic factor. LV longitudinal dysfunction can be observed by 2D strain and is more severe in patients with LFLG AS as compared with other groups. The combined evaluation of global afterload (by valvulo-arterial impedance measurement) and of longitudinal systolic function (by 2D strain measurements) provides an optimal assessment of patients with low-gradient severe AS despite normal LV ejection fraction. This evaluation may help in separating patients with low-gradient AS into 2 groups of different severity.
Conclusions: LFLG AS is observed in 9% of patients with severe AS and normal ejection fraction and is associated with high global afterload and reduced longitudinal systolic function. Patients with normal-flow low-gradient AS are more frequent and present with less severe AS, normal afterload, and less severe longitudinal dysfunction. Severe left ventricular longitudinal dysfunction is a new explanation to the concept of LFLG AS.
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Impact of Prosthesis-Patient Mismatch on the Regression of Secondary Mitral Regurgitation After Isolated Aortic Valve Replacement With a Bioprosthetic Valve in Patients With Severe Aortic Stenosis
Summary: Patients with severe aortic stenosis undergoing aortic valve replacement often show a degree of functional mitral regurgitation. Surgery on the aortic valve is expected to reduce the pressure overload of the left ventricle, thus resulting in some improvement of mitral regurgitation. In the settings of aortic prosthesis-patient mismatch, that reduction of left ventricular systolic pressures is lower because of the smaller aortic effective orifice area of such patients, and this large study demonstrates that aortic prosthesis-patient mismatch has a negative impact on the regression of concomitant functional mitral regurgitation. The clinical impact of the less effective postoperative regression of mitral regurgitation was demonstrated by the worse performance at the 6-minute walk test, although 3-year survival was similar. Left atrial diameter was the only preoperative factor associated with postoperative regression of mitral regurgitation, suggesting that one should take this into consideration in planning whether concomitant mitral valve surgery is indicated in the presence of an enlarged left atrium and at least moderate mitral regurgitation; however, given that double valve surgery carries increased morbidity and mortality risk, prosthesis-patient mismatch is a potentially modifiable risk factor that should be considered when performing aortic valve replacement and techniques employed to optimize valve size and profile.
Conclusions: PPM is associated with lesser regression of SMR following AVR. This unfavorable effect was associated with worse functional capacity. These findings emphasize the importance of operative strategies aiming to prevent PPM in patients with aortic valve stenosis and concomitant SMR.
84
Correlates of Tricuspid Regurgitation as Determined by 3D Echocardiography: Pulmonary Arterial Pressure, Ventricle Geometry, Annular Dilatation, and Papillary Muscle Displacement
Summary: There is an increasing interest in changes that occur in the tricuspid valve apparatus anatomy and the correlation of these changes with the severity of tricuspid regurgitation (TR). In the study, the authors employed 3D echocardiography to identify the papillary muscles within the right ventricle and report how their position is altered with ventricular dilatation. The authors report that pulmonary arterial pressure, ventricular size, annulus area, and papillary muscle position are predictors of the severity of TR. While tethering of the leaflets also was quantified in this study, the position of the anterior papillary muscle proved to be a better predictor of TR severity. A complete investigation of the parameters responsible in clinically significant TR, as presented here, may help guide the clinician to target repairs to the direct cause of TR, and thus may result in more durable repairs.
Conclusions: Alterations in ventricular geometry can lead to TR by altering both tricuspid annulus size and PM position. Understanding these geometric interactions with the aim of correcting pathological alterations of the tricuspid valve apparatus may lead to more robust repairs. (2) The magnitude of LGE may be more important for identifying patients at risk for generating ventricular tachyarrhythmias than merely the presence of LGE. Despite these important observations, the role of LGE in risk stratification and selection of patients for primary prevention implantable cardioverterdefibrillators is unresolved, given the lack of amply powered outcome studies. Nevertheless, the present data underscore the potential importance of assessing the extent and character of LGE (rather than only the presence of LGE) for predicting outcome in hypertrophic cardiomyopathy and should therefore be measured in a larger patient study designed to clarify the incremental prognostic value of LGE.
Conclusions: In patients with HCM, intermediate LGE-SI is a better predictor of ventricular tachyarrhythmias (including nonsustained ventricular tachycardia, a risk factor for sudden death) than is high
LGE-SI. Longitudinal studies in larger HCM cohorts are justified to define the independent prognostic impact of intermediate LGE-SI.
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Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping
Summary: Although several T2-weighted imaging techniques have been used in magnetic resonance-based assessment of inflammatory cardiomyopathies, they all require subjective or semiquantitative recognition of relative differences in signal intensity. The authors sought to overcome this limitation and to better define the presence and extent of myocardial involvement with quantitative myocardial T2 mapping in patients referred for a cardiac magnetic resonance imaging (CMR) examination for suspected myocarditis or tako-tsubo cardiomyopathy. T2 mapping identified regions of myocardial involvement extending beyond segmental wall motion abnormalities and visually abnormal T2-weighted short tau inversion recovery (T2-STIR) and bright-blood T2-weighted images and subtending a region larger than that delimited by hyperenhancement on late postgadolinium images. Diagnostic-quality T2 mapping could be performed in all patents, unlike 23% of T2-STIR images that were compromised by patients'
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Circ Cardiovasc Imaging November 2013 difficulty with breath holding. Myocardial T2 exceeding 59 ms reliably delineates the presence and extent of involvement in inflammatory cardiomyopathies with noncontrast CMR.
Conclusions: Quantitative T2 mapping reliably identifies myocardial involvement in patients with myocarditis and TTCM. T2 mapping delineated a greater extent of myocardial disease in both conditions compared with that identified by wall motion abnormalities, T2-weighted short tau inversion recovery imaging, T2-prepared steady-state-free precession, or late gadolinium enhancement. Quantitative T2 mapping warrants consideration as a robust technique to identify myocardial injury in patients with acute myocarditis or TTCM.
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Combined Cardiac Magnetic Resonance Imaging and C-Reactive Protein Levels Identify a Cohort at Low Risk for Defibrillator Firings and Death
Summary: The prevention of sudden cardiac death remains an imprecise science. Current clinical practice for selecting patients for primary prevention implantable cardioverter-defibrillators (ICDs) predominantly relies on demonstrating reduced left ventricular ejection fraction. However, this criterion lacks sensitivity and specificity. Although 80 000 Americans annually receive devices based on low left ventricular ejection fraction, only a minority (5% per year) will have appropriate ICD therapy, and a significantly larger number of patients will be subjected to the adverse effects of procedural complications, inappropriate discharges, infections, and device malfunctions. Prior studies have supported the role of the myocardial substrate in ventricular arrhythmogenesis. In the current study, the authors examined whether a combined index of myocardial tissue heterogeneity (gray zone) assessed by cardiac magnetic resonance could differentiate between low-and high-risk patients independently or in combination with serum biomarkers, such as high-sensitivity C-reactive protein. The authors prospectively enrolled 235 patients with ischemic and nonischemic cardiomyopathy. Patients who had the lowest levels of both gray zone and high-sensitivity C-reactive protein had the lowest risk of appropriate ICD discharges and cardiac death, with an annual incidence of 0.7% per year, which is below reported ICD-complication rates. These results are unique in identifying a low-risk cohort using combined risk indices that may reflect the underlying substrate and a proinflammatory environment that adversely modifies the myocardial substrate. Future prospective studies will be needed to determine whether such a strategy can be used to safely and cost-effectively reduce unnecessary ICD implantations.
Conclusions:
In a cohort of primary prevention ICD candidates, combining a myocardial heterogeneity index with an inflammatory biomarker identified a subgroup with a very low risk for adverse cardiac events, including ventricular arrhythmias. This novel approach warrants further investigation to confirm its value as a clinical risk stratification tool.
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Isolated Left Ventricular Noncompaction in Sub-Saharan Africa: A Clinical and Echocardiographic Perspective
Summary: During the past 10 years, increasing awareness of isolated left ventricular noncompaction (ILVNC), accompanied by improved diagnostic imaging techniques, have resulted in the recognition of more ILVNC cases worldwide, which allowed the clinical characteristics to be better defined. Heart failure, thromboembolism, and malignant ventricular arrhythmias are the most challenging clinical aspects of ILVNC confronting clinicians worldwide, and have contributed to the poor survival observed in these patients. In sub-Saharan Africa, the most common causes of heart failure are thought to be related to rheumatic valvular disease, peripartum and idiopathic cardiomyopathy, and hypertension. However, a large prospective modern study of heart failure in Africa that used clinical and echocardiographic assessment found 28% of all heart failure was caused by idiopathic cardiomyopathy. The authors prospectively documented the clinical and echocardiographic features of patients identified with ILVNC at their institution. ILVNC in patients of African descent is characterized by biventricular abnormality and pulmonary hypertension. Careful echocardiographic analysis is required to identify this condition. Long-term follow-up is essential to determine if patients of African descent have the same degree of morbidity and mortality as other populations.
Conclusions: ILVNC in patients of African descent can be characterized by biventricular abnormality and pulmonary hypertension, in addition to isolated left-sided abnormality.
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Patients With Syndrome X Have Normal Transmural Myocardial Perfusion and Oxygenation: A 3-T Cardiovascular Magnetic Resonance Imaging Study
Summary: The pathophysiology of chest pain in patients with syndrome X (chest pain, abnormal exercise treadmill test, normal coronary angiogram) remains controversial. Previous studies using nuclear techniques or cardiovascular magnetic resonance to assess myocardial perfusion have shown conflicting results. Other studies suggest that abnormal pain perception is a central component of the pathophysiology of this enigmatic syndrome. The authors used cardiovascular magnetic resonance to quantitatively assess regional myocardial blood flow and oxygenation during vasodilatory stress (adenosine) in patients with syndrome X and healthy controls. The findings indicate that patients with syndrome X have no evidence of transmural hypoperfusion or deoxygenation but a greater incidence of chest pain during vasodilatory stress compared with controls. Studies using high-resolution perfusion cardiovascular magnetic resonance (<1-mm in-plane resolution) are needed to further investigate subendocardial and subepicardial perfusion in these patients.
Conclusions:
Patients with syndrome X show greater sensitivity to chest pain compared with controls but no evidence of deoxygenation or hypoperfusion during vasodilatory stress. 
Morphological and Functional Adaptation of the Maternal Heart During Pregnancy
Summary: Pregnancy represents a unique model of morphological, hemodynamic, and functional adaptation of the heart in a physiological situation of transient preload and afterload changes. The characterization and understanding of maternal cardiac function during normal pregnancy is of clinical importance for the recognition of cardiac pathology because heart disease is the leading cause of nonobstetric mortality during pregnancy. The present study aimed to assess the effects of normal pregnancy on left ventricular mechanics using standard and novel morphological and functional echocardiographic parameters while considering left ventricular load and shape. The data show that local deformation parameters are more sensitive to subtle myocardial changes than classical parameters and, therefore, may be used as possible screening tools for the early detection of pregnancy-associated disorders such as peripartum cardiomyopathy and preeclampsia. Because even those parameters reflect myocardial function only modulated by ventricular geometry, shape changes of the ventricle during pregnancy must be considered, or normal values need to be adjusted to the gestational age. Further studies are needed to assess the value of the technique in different pathologies.
Conclusions: Pregnancy is a physiological process associated with increased cardiac performance and progressive LV remodeling. These changes are not directly reflected by parameters traditionally considered to describe systolic function, such as ejection fraction and longitudinal deformation. While ejection fraction was insensitive to the functional changes, the transient decrease in longitudinal deformation becomes only plausible when considering the changes in LV geometry.
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Clinical Context and Mechanism of Functional Tricuspid Regurgitation in Patients With and Without Pulmonary Hypertension
Summary: Tricuspid regurgitation is frequent but not well-understood. Most often, it occurs despite structurally normal leaflets and is termed functional tricuspid regurgitation (FTR). This study evaluated the clinical context and mechanisms of FTR in patients in whom the authors performed quantification of tricuspid regurgitation, valvular deformation, and ventricular remodeling. The authors compared 2 FTR types that were caused by pulmonary hypertension versus FTR without overt cause (id-FTR). The authors matched groups for important characteristics at diagnosis (particularly the regurgitant orifice) and also included, as controls, patients of the same age with trivial TR. The results show that id-FTR occurs in older patients mostly with Afib. This observation is important because the study shows the mechanism of idiopathic FTR to be isolated enlargement of the tricuspid annulus, a known consequence of Afib, resulting in insufficient annulus coverage by the leaflets. This annular enlargement is associated with a conical deformation of the RV, which does not cause leaflet deformation. Conversely, with pulmonary hypertension, the RV is elongated and spherically deformed, leading to leaflet traction exerted by the papillary muscles, as well as deformation and tenting of leaflets, which cannot cover the annulus, despite its modest dilatation. Thus, the mechanism of FTR is not uniform. The authors' results enhance the understanding of the context and mechanisms for FTR and may help inform improved treatment strategies.
Conclusions: Id-FTR is frequent, linked to aging and atrial fibrillation, can be severe, and is of unique mechanism. In Id-FTR, excess annular and RV-basal enlargement exhausts valvular/annular coverage reserve, and RV conical deformation does not cause notable valvular tenting. Conversely, PHTN-FTR is determined by valvular tethering with tenting linked to RV elongation and elliptical/spherical deformation. These specific FTR-mechanisms may be important in considering surgical correction in FTR. 94 
Exercise Response in Hypertrophic Cardiomyopathy: Blunted Left Ventricular Deformational and Twisting Reserve With Altered Systolic-Diastolic Coupling
Summary: The authors investigated the adaptation of left ventricular (LV) strains and twist-untwist mechanics in hypertrophic cardiomyopathy (HCM) patients, who typically show exercise-induced symptoms. At rest, HCM patients showed lower longitudinal strain than control subjects, and this was compensated for by higher circumferential strain and twist. During exercise, however, HCM patients exhibited a severely limited adaptability of all strain components with no LV twisting reserve, reduced and delayed untwist mechanics, and reduced systolic-diastolic coupling efficiency. Exercise echocardiography with evaluation of LV twisting and deformational reserve might be a useful clinical tool in other cardiac pathologies, particularly in differentiating physiological and pathological hypertrophy. As opposed to pathological hypertrophy, the athlete's heart would be expected to have an increased twisting and deformational reserve. However, this must be confirmed in further comparative studies.
Conclusions: HCM patients had severely limited strain adaptability and no LV twisting reserve at exercise. They had reduced and delayed UTR with reduced systolic-diastolic coupling efficiency by twistuntwist mechanics.
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Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy
Summary: The authors used cardiovascular MR to define the prevalence as well as clinical course and diagnostic significance of left ventricular myocardial crypts (ie, narrow and deep bloodfilled invaginations contiguous with the left ventricular cavity, extending ≥50% of wall thickness) across the broad hypertrophic cardiomyopathy spectrum. Crypts were identified in 61% of asymptomatic genotype-positive/phenotype hypertrophic cardiomyopathy family members compared with only 4% of patients with hypertrophic cardiomyopathy with left ventricular hypertrophy (P<0.001). These observations expand the appreciation of diverse hypertrophic cardiomyopathy expression, particularly with respect to genotype-positive/phenotype-negative patients, and are a potential novel cardiovascular MR imaging marker for genotype-positive status in the absence of left ventricular hypertrophy, constituting an impetus to perform genetic testing to achieve definitive diagnosis.
Conclusions: LV myocardial crypts represent a distinctive morphological expression of HCM, occurring with different frequency in HCM patients with or without LV hypertrophy. Crypts are a novel cardiovascular MR imaging marker, which may identify individual HCM family members who should also be considered for diagnostic genetic testing. These data support an expanded role for cardiovascular MR in early evaluation of HCM families.
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Bicuspid Aortic Valve Is Associated With Altered Wall Shear Stress in the Ascending Aorta
Summary: This study investigates wall shear stress (WSS) in the thoracic aorta of bicuspid aortic valve (BAV) patients stratified by a specific valve fusion morphology. The main findings of this investigation are that (1) a right-left BAV fusion pattern was associated with significantly and focally elevated WSS in the ascending aorta, (2) this elevation was present both in stenotic and nonstenotic right-left BAV patients, (3) the postvalvular blood flow jet direction was influenced by the position of the fused cusp, and (4) aortic wall/jet impingement positions corresponded to regions of elevated WSS. Evidence is presented showing a mechanism by which impaired cusp mobility may elevate local aortic WSS downstream from the aortic valve. This phenomenon is of interest, given the heterogeneous expression of aortopathy in BAV patients with specific valve fusion patterns and valve lesions. On the basis of previous findings indicating that increased WSS is associated with altered endothelial cell function and vascular remodeling, the results in this study illustrate WSS patterns as a differentiating characteristic between valve fusion groups beyond genetic predisposition and could be used for risk stratification and clinical decision making. The guidelines for the management of BAV patients with concomitant aortopathy mainly focus on the absolute size of the aorta, the condition of the valve, and the rate of aorta expansion. Information about the hemodynamic forces exerted on the ascending aorta wall as described in this study may help to complement these dimensional measurements and to facilitate more individualized patient management.
Conclusions:
The results of this study demonstrate that bicuspid valves induced significantly altered ascending aorta hemodynamics compared with age-and size-matched controls with tricuspid valves. Specifically, the expression of increased and asymmetric WSS at the aorta wall was related to ascending aortic flow jet patterns, which were influenced by the BAV fusion pattern.
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Impact of Frequent Nocturnal Hemodialysis on Myocardial Mechanics and Cardiomyocyte Gene Expression
Summary: Diastolic dysfunction is common in patients with end-stage renal disease. Myocardial mechanics were assessed by 2-dimensional velocity vector imaging in 29 normal subjects and in 42 patients with end-stage renal disease before and after conversion from conventional hemodialysis (3 times a week, 4 hours per session) to nocturnal hemodialysis (5-6 nights a week, 6-8 hours per session). Gene expression profile from neonatal Sprague-Dawley rat ventricular myocytes was also examined before and after conversion to nocturnal hemodialysis. With nocturnal hemodialysis, left ventricular mass index and left atrial volume index decreased. Left ventricular apical circumferential strain and basal rotation improved after conversion to nocturnal hemodialysis and approximated normal values. Under conventional hemodialysis conditions, there was an upregulation of genes leading to apoptosis and fibrosis in cardiomyocytes.
Conclusions: Frequent hemodialysis is associated with improvement in myocardial mechanics and cardiac gene expression profile, which warrants prognostic validation.
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Cardiac Micro-Computed Tomography Imaging of the Aging Coronary Vasculature
Summary: The aging heart is susceptible to structural and functional changes that increase the risk of heart failure, which continues to rise in the aging population. Although seminal advances have been made in understanding changes to the cardiomyocyte and extracellular matrix in aging as well as in disease, less has been made on global alterations of the coronary vasculature. The authors' study aimed to provide insights into age-associated changes in the coronary vasculature using high-resolution microcomputed tomography (micro-CT) imaging technology. This technology gives us the ability to evaluate the entire coronary circulation, which the authors are unable to do with conventional histomorphometric techniques. In this study, using an experimental Fischer rat model of aging, the authors demonstrated important changes in the epicardial and intramyocardial coronary vessels, at varying arterial luminal diameters, between young and aged Fischer rats using micro-CT imaging. Specifically, in the setting of a growing myocardium due to aging, the authors observed the increase in epicardial coronary vessel volume, whereas the intramyocardial coronary vessel volume was reduced. Hence, cardiac micro-CT technology represents a powerful imaging tool that provides a greater and more representative understanding of adaptive changes to the entire coronary circulation in aging and could also provide important insights into other pathological states as well.
Conclusions: This micro-CT imaging study reports the reduction in normalized intramyocardial vessel volume within the aged heart, in association with increased epicardial vessel volume, in the setting of increased LV fibrosis, and mild LV dysfunction.
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Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Summary: Because cancer patients survive longer, the impact of cardiotoxicity associated with the use of cancer treatments on cardiac morbidity and mortality is increasing. Left ventricular ejection fraction is the recognized method to monitor the cardiotoxic effects of cancer treatments; however, it may not detect subtle myocardial injury. The present study investigated whether early alterations of myocardial strain and blood biomarkers could predict incident cardiotoxicity in a cohort of 81 patients with breast cancer during treatment with anthracyclines followed by taxanes and trastuzumab. Peak systolic longitudinal myocardial strain and ultrasensitive troponin I measured after completion of the anthracyclines were predictive of cardiotoxicity (defined by a decrease of left ventricular ejection fraction with or without symptoms of heart failure) occurring later during the treatment.
Conclusions:
In patients with breast cancer treated with anthracyclines, taxanes, and trastuzumab, systolic longitudinal myocardial strain and ultrasensitive troponin I measured at the completion of anthracyclines therapy are useful in the prediction of subsequent cardiotoxicity and may help guide treatment to avoid cardiac side-effects. 
Global Strain in Severe Aortic Valve Stenosis: Relation to Clinical Outcome After Aortic Valve Replacement
Summary: Aortic valve stenosis (AS) leads to left ventricular remodeling and compromised coronary flow reserve that gradually affects systolic and diastolic function. Left ventricular ejection fraction is the most routinely used parameter when assessing left ventricular systolic function. However, it is well known that in AS, ejection fraction may remain normal despite reduced myocardial contractility. The use of speckle tracking allows assessment of systolic strain, which reflects longitudinal and radial myocardial function. As early myocardial alterations are primarily known to affect longitudinal myocardial fibers, the use of longitudinal strain analysis may be useful in AS in identifying patients with reduced contractility despite normal ejection fraction. Identification of this population is important, as reduced contractility may lead to increased long-term mortality despite aortic valve replacement. The authors have demonstrated that global strain is independently associated with long-term postoperative cardiac mortality and morbidity in symptomatic patients with severe aortic valve stenosis and preserved ejection after aortic valve surgery. Future studies should be performed on asymptomatic patients to clarify whether patients with reduced global strain would benefit from early surgery.
Conclusions:
In patients with symptomatic severe aortic stenosis undergoing aortic valve replacement, reduced GLS provides important prognostic information beyond standard risk factors. 
Non-Circular Shape of Right Ventricular Outflow Tract: A Real-Time 3-Dimensional Transesophageal Echocardiography Study
Summary: The assessment of right ventricular outflow tract (RVOT) is of clinical importance for measuring right-sided stroke volume, Qp/Qs, and regurgitant fraction. Conventional 2-dimensional (2D) echocardiography is one of the modalities for assessing the RVOT; however, the authors often find a discrepancy between noninvasive and invasive assessment. Recently, pulmonary valve replacement using a transcatheter device has been reported. Therefore, an understanding of RVOT morphology and function may be important in the clinical management of various cardiopulmonary diseases. Nevertheless, RVOT geometry and function have not been fully evaluated. In this study, 3-dimensional transesophageal echocardiography (3D TEE) revealed that RVOT geometry was not generally circular but oval with 2 different types. 3D TEE provided detailed morphological information about the RVOT, which allowed more accurate assessment of cardiac output than 2D TEE. In addition, the angle between the basal interventricular septum and the axis of the aortic root (septoaortic angle) was shown to be a determinant of RVOT shape; the more acute this angle becomes, the more vertical the RVOT shape is. As earlier studies have reported, aging strongly affects RVOT shape and the angle becomes more acute with aging. As a future direction, the authors propose that the precise assessment of RVOT shape using 3D TEE may contribute to improved catheterbased treatment outcomes.
Conclusions: 3D TEE revealed that RVOT geometry was not generally circular but oval with 2 different types. Because of the detailed morphological information of RVOT, 3D TEE could provide more accurate assessment of CO than 2D TEE.
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Association of Myocardial Deformation With Outcome in Asymptomatic Aortic Stenosis With Normal Ejection Fraction
Summary: The management of patients with asymptomatic severe aortic stenosis remains controversial. Valve replacement is usually considered in the presence of overt left ventricular (LV) dysfunction. However, emerging data suggest that impaired myocyte function occurs early in the course of aortic stenosis and may be significant even in the presence of preserved LV ejection fraction. In the current study, the authors sought to determine whether LV global longitudinal strain, an indicator of subclinical LV systolic dysfunction, would provide prognostic information in these patients. The authors' results indicate that patients with mean absolute global longitudinal strain >15% had significantly better outcomes than patients with strain <15% (4-year survival of 39% versus 16%; P=0.009), and this measurement added incremental prognostic value to Society of Thoracic Surgeons score, transaortic peak pressure gradient, aortic valve calcification, and valvulo-arterial impedance. These results emphasize that both the state of the valve and the LV must be considered when assessing the risk of cardiovascular events in patients with asymptomatic severe aortic stenosis.
Conclusions: GLS is associated with outcomes in patients with severe asymptomatic aortic stenosis, incremental to other clinical and echocardiographic variables. demonstrate aldosterone-mediated cardiac fibrosis have been inferred by using 2-dimensional echocardiography and videodensitometry, as well as measuring plasma markers of collagen turnover. The current study is the first to use contrast-enhanced cardiac magnetic resonance imaging, the gold standard imaging technique for myocardial fibrosis, to demonstrate the effects of aldosterone excess in subjects with no evidence of coronary artery disease. The authors' data provide further evidence that myocardial fibrosis can occur due to aldosterone-mediated cardiac damage that is independent of blood pressure. These results highlight the importance of early diagnosis of this condition in subjects with high blood pressure. They suggest that treatment strategies should be aimed at ameliorating the effects of aldosterone excess as well as lowering blood pressure. Whether aldosterone-mediated cardiac fibrosis is reversible with treatment of aldosterone excess remains to be seen.
Conclusions: These data illustrate that patients with PA exhibit frequent myocardial fibrosis as demonstrated by late gadolinium enhancement using cardiac magnetic resonance imaging; this finding is independent of blood pressure. This may be mediated partly through inflammation and oxidative stress. This study highlights the importance of specific targeting of aldosterone excess as well as blood pressure reduction to minimize cardiac morbidity in PA.
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Analysis of Procedural Effects of Percutaneous Edge-to-Edge Mitral Valve Repair by 2D and 3D Echocardiography
Summary: Percutaneous mitral valve repair has been demonstrated to be effective for reduction of mitral regurgitation. However, commonly used 2 dimensional (2D) echocardiography based techniques are not validated for postprocedure double-orifice mitral valve and may be limited in the accurate quantification of procedural effects on mitral morphology and function. This study showed that mitral valve regurgitant volumes pre-and postpercutaneous mitral valve repair can be evaluated with lower intra-and interobserver variability using 3D transesophageal echocardiography (TEE) compared with 2D echocardiography-based methods. This may allow better assessment of procedural effects during serial analysis of mitral regurgitant severity pre-to postprocedure. Three dimensional TEE used for preprocedural analysis of mitral valve morphology allows definition of patients with greater procedural effectiveness and greater risk of postprocedural mitral valve stenosis. Furthermore, the 3D TEE-based analysis of procedural effectiveness allows an improved definition of patients with subsequent left atrial and left ventricular remodeling. In clinical practice, preprocedural 3D TEE based analysis of the mitral valve geometry may be used to predict the effectiveness of percutaneous mitral valve repair and postprocedural application of 3D TEE allows an improved understanding of the morphological and functional changes induced by the intervention. Summary: Increasingly, changes in metabolic substrate use and depleted myocardial energetics are considered to be causes, rather than consequences, of heart failure. Recent experimental studies have demonstrated that monitoring hyperpolarized 13C-labeled tracers with magnetic resonance spectroscopy offers a new, noninvasive method to investigate cardiac metabolism, and that the technology may be useful to determine diagnosis and prognosis and to optimize management of patients with heart disease. In the present study, the authors used the metabolic tracer hyperpolarized [2-13C]pyruvate with magnetic resonance spectroscopy to show that in healthy hearts, acetyl-coenzyme A formed from pyruvate rapidly cycles through the mitochondrial acetylcarnitine pool. Further, the authors demonstrated that the acetylcarnitine pool functions in vivo to continually fine-tune mitochondrial acetyl-coenzyme A levels, providing an overflow pool to prevent potentially deleterious acetyl-coenzyme A accumulation and a source of energetic substrate in response to rapidly increased cardiac workload. Many physiological and pathological conditions, including aging, hypertrophy, and heart failure, are characterized by depleted myocardial carnitine stores and energy depletion. Noninvasive assessment of the acetylcarnitine pool and other metabolic processes using hyperpolarized 13C magnetic resonance spectroscopy may advance understanding of the importance of carnitine in heart failure, related abnormalities in heart failure, and targeted metabolic treatments.
Conclusions
Conclusions: Hyperpolarized 13C magnetic resonance spectroscopy has revealed that acetylcarnitine provides a route of disposal for excess acetyl-CoA and a means to replenish acetyl-CoA when cardiac workload is increased. Cycling of acetyl-CoA through acetylcarnitine appears key to matching instantaneous acetyl-CoA supply with metabolic demand, thereby helping to balance myocardial substrate supply and contractile function. Summary: Carotid intraplaque hemorrhage has been associated with symptomatic stroke and can be accurately detected with magnetization-prepared rapid acquisition with gradient-echo (MPRAGE). However, an association between carotid hemorrhage, as detected by MPRAGE signal, and territorial ischemic events, as detected by diffusion restriction in the acute setting, has not been shown. The authors' aim was to determine the association of carotid MPRAGE signal with acute territorial ischemic events using carotid MPRAGE and brain diffusion tensor imaging in patients with suspected acute stroke within 24 hours. In patients undergoing acute stroke workup, MPRAGE-positive carotid plaque was associated with acute territorial ischemic events detected by brain diffusion tensor imaging. This association was present across all categories of carotid stenosis. These data add further support to the understanding of the pathophysiology of carotid embolic stroke and the notion of MPRAGE-positive plaques as a marker of vulnerability with increased risk of embolic events. Routine use of the MPRAGE sequence may lead to improved risk assessment for stroke in patients with carotid disease, which may greatly improve diagnosis of cerebral embolic sources. Clinical trials to determine the optimal treatment for patients with vulnerable carotid plaque are warranted.
Conclusions:
In the workup of acute stroke, carotid MPRAGE-positive signal was associated with an increased risk of territorial cerebral ischemic events as detected objectively by brain diffusion tensor imaging. The relative risk of stroke was increased in all carotid stenosis categories but was most elevated in the mild stenosis category. 
3.0T Whole-Heart Coronary Magnetic Resonance Angiography Performed With 32-Channel Cardiac Coils: A Single-Center Experience
Summary: Coronary imaging with magnetic resonance has historically been challenging, but recent technical advantages may overcome prior limitations to reliable detection of coronary artery stenosis. This study evaluated whole-heart navigator-gated, ECG-triggered and free-breathing coronary magnetic resonance angiography acquired after intravenous infusion of gadolinium-based contrast successfully performed in 101 patients also undergoing traditional invasive x-ray angiography. Magnetic resonance angiography acquisition time averaged 7.0±1.8 minutes. For a cutoff of 50% luminal stenosis by quantitative coronary angiography, 3-dimensional magnetic resonance angiography performed well, with positive and negative predictive values averaging 87.0% and 95.7%, respectively. With contemporary techniques, coronary magnetic resonance angiography can be performed efficiently, and warrants greater consideration as a suitable noninvasive method to exclude obstructive coronary artery disease.
Conclusions:
The authors have therefore conducted a prospective study to evaluate the diagnostic performance of 3.0T whole-heart coronary MRA using a 32-channel cardiac coil compared with quantitative x-ray coronary angiography in patients with suspected CAD. demonstrate that cardiac magnetic resonance, a noninvasive test for acute transplant rejection, offers a direct clinical marker in the diagnosis of cardiac transplant rejection. In particular, this study showed that quantitative T2 mapping by cardiac magnetic resonance showed increased myocardial T2 in patients with acute rejection. Secondarily, the study demonstrates that quantitative T2 mapping may be useful in assessing the response to therapy. Specifically, resolution of elevated T2 relaxation may indicate that the treatment for acute rejection was successful; if T2 values remain elevated, this may indicate ongoing rejection. The benefits of ECG-gated steady-state free precessionbased quantitative T2 mapping over previous cardiac magnetic resonance techniques are that this method removes the subjectivity found with T2-weighted imaging. This subjectivity is found not only in T2-weighted imaging but also in analyzing endomyocardial biopsy pathology. Finally, cardiac magnetic resonance provides insight into the entire myocardium, whereas endomyocardial biopsy suffers from sampling bias. Thus, quantitative T2 mapping offers rapid, noninvasive myocardial assessment for cardiac transplant patients, which further does not require administration of any contrast agent. Further investigations are warranted to determine whether abnormalities by T2 mapping could guide more selective use of endomyocardial biopsy in post-transplant patients or prompt changes in management such as immunosuppression regimen.
Conclusions: Quantitative T2 mapping offers a novel noninvasive tool for transplant monitoring, and these initial findings suggest potential use in characterizing rejections. Given the limited numbers, a larger multi-institution study may help elucidate the benefits of T2 mapping as an adjunctive tool in routine monitoring of cardiac transplants.
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Reference Values for Normal Pulmonary Artery Dimensions by Noncontrast Cardiac Computed Tomography: The Framingham Heart Study
Summary: In noncontrast multi-detector computed tomography (CT), both main pulmonary artery (mPA) diameter and ratio of the mPA to the ascending aorta (ratio PA) measurements are easily obtained and highly reproducible. This simple measurement of axial mPA diameter at the level of the bifurcation of the right pulmonary artery is easy to define anatomically. The ascending aorta can be simultaneously measured to provide a quick calculation of the ratio PA. The authors defined the healthy referent cohort (706 of 3171 participants from the Framingham Heart Study) as those without obesity, hypertension, current and past smokers, chronic obstructive pulmonary disease, history of pulmonary embolism, diabetics, cardiovascular disease, and heart valve surgery. Using the 90th percentile, the sex-specific CT cutoff value for mPA for men is 29 mm and for women is 27 mm and for ratio PA is 0.9 for both men and women. These cutoff values may be useful for MRI also, if measured at the same location. Enlarged mPA is associated with multiple cardiovascular risk factors, prevalent cardiovascular disease, and dyspnea. These 2 simple measurements may hold some promise for the preclinical diagnosis for the "silent diseases" of the cardiopulmonary system, such as early pulmonary arterial hypertension or early left heart disease (pulmonary venous hypertension) or a mixed process. The authors' findings are an important beginning of a more complete understanding of the variability of PA measurements and how they may correlate with cardiopulmonary disease. Future studies should aim at determining if these parameters may represent subclinical disease.
Conclusions: For simplicity, the authors established 29 mm in men and 27 mm in women as sex-specific normative reference values for mPA and 0.9 for ratio PA. Compared with stent <20 months after implantation (the best cut-off to predict TCFA-containing neointima), stent ≥20 months after implantation had a higher incidence of TCFA-containing neointima (69% versus 33%, P=0.012) and red thrombi (27% versus 0%, P=0.007). Postintervention creatine kinase MB was significantly higher in intimal rupture versus no intimal rupture (P=0.025). The rate of agreement between grayscale intravascular ultrasound and OCT for detecting intimal rupture was 50% and for detecting thrombus was 44%. In the virtual histology intravascular ultrasound subgroup (N=32), the agreement between virtual histology intravascular ultrasound and OCT for identifying TCFA-containing neointima was 78%.
Conclusions:
In-stent neoatherosclerosis may be an important mechanism of DES failure, especially late after implantation.
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Detection of Intracoronary Thrombus by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction
Summary: Non-ST-segment-elevation acute coronary syndromes represent a growing clinical challenge in that most acute coronary syndromes or acute myocardial infarctions are not associated with ST-elevation myocardial infarction. Although patients with ECG changes indicative of ischemia and/or positive biomarkers of myocardial necrosis should be considered for early coronary angiography, differential diagnosis and treatment in the remaining spectrum of patients are challenging. This heterogeneous group includes a subgroup that would benefit from very early intervention (<24 hours), whereas others may have an improved outcome with initial medical optimization, including antiplatelet and antithrombotic treatment.
Conventional clinical risk-scoring methods have not been able to clearly distinguish these groups. Because the majority of acute coronary syndromes are believed to be caused by rupture or erosion of an atherosclerotic plaque with subsequent intraluminal thrombosis resulting in partial or complete occlusion of a coronary artery, a technique that allows noninvasive detection of thrombus may further enhance risk stratification and allow treatment to be tailored in this high-risk population.
Conclusions: Use of MRDTI allows selective visualization of coronary thrombus in a patient population with a high probability of intracoronary thrombosis.
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Acute Hypoglycemia Decreases Myocardial Blood Flow Reserve in Patients With Type 1 Diabetes Mellitus and in Healthy Humans
Summary: Hypoglycemia is a common problem that occurs in almost 20% of patients receiving intensive insulin therapy in hospital. Several studies have recently shown that hypoglycemia is associated with an increase in cardiovascular mortality. This association has been demonstrated in people with and without established coronary artery disease. Importantly, patients with acute coronary syndromes appear to have worse short-and long-term outcomes if they experience hypoglycemia in the acute phase of their presentation. The pathophysiological mechanism responsible for this association is not known. This present study examined the effects of hypoglycemia on myocardial blood flow (MBF) reserve using myocardial contrast echocardiography in subjects with type 1 diabetes mellitus and healthy control subjects. With the use of a 1-step hyperinsulinemic clamp technique, insulin-induced hypoglycemia decreased the MBF reserve in both patients with type 1 diabetes mellitus and healthy subjects. Furthermore, during hyperinsulinemic euglycemia, insulin induced a marked increase in peak MBF and MBF reserve, whereas hypoglycemia led to an increase in resting MBF and a decrease in peak MBF, thereby decreasing the MBF reserve overall. This effect was observed in both healthy individuals and patients with type 1 diabetes mellitus.
Conclusions: Hypoglycemia decreases MBFR in both healthy humans and patients with DM. This finding may explain the association between hypoglycemia and increased cardiovascular mortality in susceptible individuals. Summary: The beneficial effects of cardiac resynchronization therapy on long-term survival are influenced by several pathophysiological factors. The present study demonstrated the relative merits of left ventricular (LV) dyssynchrony, LV lead position, and myocardial scar to predict long-term outcome of ischemic heart failure patients treated with cardiac resynchronization therapy. With speckle tracking radial strain analysis, the extent of LV dyssynchrony, site of latest mechanical activation, and presence of myocardial scar at the LV segment where the LV pacing lead is placed were evaluated. In addition, the LV lead position was derived from chest x-ray and was defined as concordant when the LV pacing lead coincided with the site of latest mechanical activation. Mean baseline LV radial dyssynchrony was 133±98 milliseconds. A concordant LV lead position was reported in 271 patients (68%), and the mean value of peak radial strain at the targeted segment was 18.9±12.6%. During a median follow-up of 21 months, 88 patients (22%) died. Larger LV radial dyssynchrony at baseline was an independent predictor of superior long-term survival (hazard ratio, 0.995 per 1-millisecond increment; P=0.001), whereas a discordant LV lead position (hazard ratio, 2.086; P=0.001) and myocardial scar in the segment targeted by the LV lead (hazard ratio, 2.913; P<0.001) were independent predictors of worse outcome. Addition of these 3 parameters yielded incremental prognostic value over the combination of clinical parameters. These data underscore the need for integrated evaluation that includes assessment of these 3 parameters to further improve patient selection and survival after cardiac resynchronization therapy.
Conclusions: Baseline LV radial dyssynchrony, discordant LV lead position, and myocardial scar in the region of the LV pacing lead
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were independent determinants of long-term prognosis in ischemic heart failure patients treated with cardiac resynchronization therapy. Larger baseline LV dyssynchrony predicted superior long-term survival, whereas discordant LV lead position and myocardial scar predicted worse outcome. The primary clinical significance of this article lies in the importance of gaining a better understanding of the underlying mechanisms resulting from hyperthyroidism. Using both noninvasive and novel techniques, the authors have thoroughly characterized the relationship between the metabolic and functional consequences of hyperthyroidism. By studying the metabolic perturbations associated with hyperthyroidism and using this information to devise a treatment regimen to improve metabolic flexibility in the hyperthyroid heart, the authors have uniquely shown that the associated cardiac hypertrophy can be reduced. The authors have also found that under conditions of plentiful energy supply, the heart is able to alter its response to maintain cardiac output. These findings are undoubtedly important, not only for this disease but also for other metabolic diseases affecting the heart. Furthermore, the potential to study the metabolic effects of hyperthyroidism and other cardiovascular diseases in humans with the hyperpolarized techniques presented here is clear. The first trials in humans with hyperpolarized pyruvate as a metabolic biomarker are imminent and offer many advantages over other forms of metabolic assessment such as including no radiation exposure and being a minimally invasive procedure. Metabolic studies with this technology can be integrated into existing magnetic resonance imaging assessments of cardiac structure and function, as demonstrated here with a combined cine magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy assessment.
Conclusions: This work has demonstrated that inhibition of glucose oxidation in the hyperthyroid heart in vivo is mediated by pyruvate dehydrogenase kinase. Relieving this inhibition can increase the metabolic flexibility of the hyperthyroid heart and reduce the level of hypertrophy that develops while maintaining the increased cardiac output required to meet the higher systemic metabolic demand.
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On T2* Magnetic Resonance and Cardiac Iron
Summary: Measurement of myocardial iron is key to the clinical management of patients at risk of iron-overload cardiomyopathy, which is a major killer in transfusion-dependent patients and others with errors of iron metabolism. This applies especially to the large cohort of β-thalassemia major patients, in whom iron accumulation leads to damage in the liver, heart, and endocrine organs. Myocardial iron is assessed clinically with the cardiovascular magnetic resonance relaxation parameter T2*. This study describes the calibration of cardiovascular magnetic resonance relaxation against human iron concentration and the iron distribution throughout the heart under conditions of iron overload. A strong correlation was observed between cardiovascular magnetic resonance relaxation measurements and biochemically derived tissue iron concentration in 12 postmortem human hearts from transfusion-dependent patients, leading to a clinical calibration equation of [Fe]=45.0×(T2*)−1.22, where [Fe] is measured in milligrams per gram dry weight and T2* is measured in milliseconds. There was no systematic variation iron concentration throughout the heart, but higher iron levels were found in the epicardium than in the endocardium. The data also show that cardiovascular magnetic resonance measurements in the midventricular septum are very representative of whole-heart iron concentration, which validates the current clinical approach in widespread use.
Conclusions: These data detail the iron distribution throughout the heart in iron overload and provide calibration in humans for cardiovascular magnetic resonance R2* against myocardial iron concentration. The iron values are of considerable interest in terms of the level of cardiac iron associated with iron-related death and indicate that the heart is more sensitive to iron loading than the liver. The results also validate the current clinical practice of monitoring cardiac iron in vivo by cardiovascular magnetic resonance of the midseptum.
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Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
Summary: Mutations in genes encoding proteins of the cardiac sarcomere are responsible for left ventricular hypertrophy, the diagnostic sine qua non of hypertrophic cardiomyopathy (HCM). However, whether other morphological features of HCM, seemingly unrelated to sarcomere mutations, are part of the disease phenotype is uncertain. The authors used cardiovascular magnetic resonance to characterize mitral valve abnormalities in a cohort of patients with HCM. Both anterior and posterior mitral valve leaflet lengths were greater among HCM patients compared with an age-and sex-matched control population (26±5 versus 19±5 mm, P<0.001; and 14±4 versus 10±3 mm, P<0.001, respectively), including more than one third of HCM patients in whom one or both of the mitral leaflets were substantially increased in length. In HCM patients, there was no relationship between mitral valve leaflet length and a number of clinical and demographic variables, including age, maximal left ventricular wall thickness, or left ventricular mass. In addition, elongated mitral valve leaflets were often the only clinical manifestation present in HCM family members carrying a sarcomere mutation without left ventricular hypertrophy and can represent the sole clinical marker of genotype-positive status. Elongated mitral valve leaflets were an important determinant of left ventricular outflow obstruction, particularly in patients in whom anterior mitral leaflet length exceeded 2-fold the transverse dimension of the outflow tract. These cardiovascular magnetic resonance-based observations show that structural abnormalities of the mitral valve represent a primary expression of the HCM phenotype and a morphological marker that may aid in diagnostic and management strategies, including optimal planning for septal reduction therapy.
Conclusions:
In HCM, mitral valve leaflets are elongated independently of other disease variables, likely constituting a primary phenotypic expression of this heterogeneous disease, and are an important morphological abnormality responsible for LV outflow obstruction in combination with small outflow tract dimension. These findings suggest a novel role for cardiac magnetic resonance in the assessment of HCM.
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Echocardiographic Markers of Elevated Pulmonary Pressure and Left Ventricular Diastolic Dysfunction Are Associated With Exercise Intolerance in Adults and Adolescents With Homozygous Sickle Cell Anemia in the United States and United Kingdom
Summary: Sickle cell disease, the most common inherited blood disorder in the United States, is a multisystem disease. It is characterized by episodes of acute illness; progressive organ damage in the spleen, joints, and kidneys as well as early mortality. Until recently, cardiopulmonary complications were not commonly recognized. With newer treatment options that prolong survival, clinical studies have shown that these patients also develop right and left heart dysfunction. Noninvasively measured elevations in pulmonary pressures and left ventricular diastolic dysfunction have been found to be independent predictors of mortality. In this observational study of 483 subjects with sickle cell disease, approximately one third had elevated pulmonary pressures by echocardiography. These patients had higher levels of hemolytic markers and serum erythropoietin and decreased renal function. Tissue Doppler-estimated filling pressures were used to assess diastolic dysfunction, and patients with a higher E/e′ ratio were older, had higher body mass index and systemic blood pressure, and had lower hemoglobin concentration. They also had higher pulmonary systolic pressure. Sickle cell disease patients can develop significant exercise limitations. In this cohort, women and older individuals were more likely to have a shorter 6-minute walk distance. Pulmonary pressure elevations and diastolic dysfunction were also independent predictors of a lower 6-minute walk distance. Both of these risk markers are now recognized as important parameters of poor outcome in sickle cell disease and may help target patients for future treatment studies.
Conclusions: Echocardiography-estimated elevated pulmonary artery systolic pressure and LV lateral E/e′ ratio were independently associated with poor exercise capacity in a large cohort of patients with sickle cell anemia. Controlled trials investigating whether strategies to prevent or delay pulmonary hypertension and/or LV diastolic dysfunction will improve exercise capacity and long-term outcomes in sickle cell anemia should be considered.
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Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict The Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study
Summary: Constrictive pericarditis (CP) is a disabling disease and usually requires pericardiectomy to relieve heart failure symptoms. Reversible cases of CP after antiinflammatory therapy have been described, but there is no known method to predict the reversibility. The authors report the pilot study to assess whether cardiac magnetic resonance imaging (CMR) pericardial late gadolinium enhancement (LGE) can predict the reversibility of CP after a course of antiinflammatory therapy. Twenty-nine patients received antiinflammatory medications after CMR. Fourteen patients had resolution of CP, whereas 15 had persistent constrictive physiology. Baseline LGE pericardial thickness was greater in the reversible CP group than in the persistent CP group. Qualitatively rated severity of pericardial LGE was moderate or severe in 93% of the reversible CP group versus 33% of the persistent CP group. CMR LGE pericardial thickness ≥3 mm had 86% sensitivity and 80% specificity to predict reversibility. The reversible CP group also had a higher baseline C-reactive protein and erythrocyte sedimentation rate level than the persistent CP group. Antiinflammatory therapy was associated with a reduction in pericardial LGE, C-reactive protein, and erythrocyte sedimentation rate in the reversible CP group but not in the persistent CP group.
Conclusions: Reversible CP was associated with pericardial and systemic inflammation. Antiinflammatory therapy was associated with a reduction in pericardial and systemic inflammation and LGE pericardial thickness, with resolution of CP physiology and symptoms.
Further studies in a larger number of patients are needed.
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Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity
Summary: Despite the fact that obesity is characterized by diastolic dysfunction, a condition associated with future heart failure, the mechanisms behind it are not known. In this study, the authors have demonstrated that myocardial energetics are impaired in obesity and that the phosphocreatine/ATP ratio is a predictor of diastolic function. This opens the possibility of a metabolic therapy aimed at improving myocardial energetics in obesity and potentially preventing the progression to heart failure. In addition, the authors have shown that during moderate inotropic stress, the already lower phosphocreatine/ ATP ratio in obesity is further reduced, resulting in additional negative effects on diastolic function. Because the majority of the cardiovascular symptoms in obesity do not occur at rest and occur in subjects with normal left ventricular systolic and respiratory function, these changes in energetics and diastole provide a plausible explanation for exertional breathlessness in obesity.
Conclusions: In obesity, cardiac energetics are further deranged during inotropic stress, in association with continued diastolic dysfunction. Myocardial energetics may play a key role in the impairment of diastolic function in obesity. Summary: Left ventricular (LV) systolic torsion limits myocardial energy consumption and minimizes transmural fiber stress gradients and oxygen demand, resulting in a more efficient contraction in the mathematical model. According to the lever-arm theory, a greater radius difference between the endocardium and the epicardium such as concentric hypertrophy would result in increased torsion. In addition, reduced subendocardial function would result in less opposition to the dominant epicardium and finally enhanced torsion because helical contraction of subendocardial and subepicardial muscle layers would counteract one another. However, the influence of LV remodeling associated with age, sex, and hypertension on LV torsion is not well understood. Therefore, the authors used cardiac magnetic resonance imaging to examine LV structure and function among 1478 participants of the Multi-Ethnic Study of Atherosclerosis who had no cardiovascular disease at baseline.
In multivariable regression models, older age was associated with lower LV volumes, higher relative wall thickness, and a significant fall in stoke volume, along with lower myocardial shortening. However, torsion was greater with old age (0.14°/cm per decade; P<0.001). The smaller LV and higher contraction of women's hearts were accompanied by the greater torsion (0.37°/cm versus men; P<0.001). Finally, although hypertension is associated with concentric hypertrophy and lower circumferential shortening, torsion is greater in hypertensive individuals independently of age and sex (0.17°/cm versus nonhypertension; P<0.05).
Conclusions:
Older age is associated with lower LV volumes and greater relative wall thickness and is accompanied by lower circumferential myocardial shortening, whereas torsion is greater with older age. Hypertensive individuals have greater LV volumes and relative wall thickness and lower circumferential shortening. Torsion, however, is greater in hypertension independently of age and sex. Torsion may therefore represent a compensatory mechanism to maintain an adequate stroke volume and cardiac output in the face of the progressively reduced LV volumes and myocardial shortening associated with hypertension and aging. Conclusions: Aortic dissection with persistent patent false lumen carries a high risk of complications. In addition to Marfan syndrome and aorta diameter, a large entry tear located in the proximal part of the dissection identifies a high-risk subgroup of patients who may benefit from earlier and more aggressive therapy.
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Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis
Summary: Aortic stenosis is the most common form of valvular heart disease in the Western world and represents a major healthcare burden that is projected to increase with an aging population. However, there are currently no effective medical treatments or biomarkers of disease activity. The pathogenesis of aortic stenosis is incompletely understood, and defining the various stages of this process will be highly important to develop the therapies and biomarkers that are required. Positron emission tomography combined with computed tomography is a noninvasive imaging technique that allows the identification and quantification of specific pathological processes within small anatomic structures, such as the aortic valve. In this study, the authors sought to test the feasibility, repeatability, and validity of this technique in the evaluation of aortic valve stenosis. Positron emission tomography/computed tomography imaging of the aortic valve was performed to assess inflammation (18F-fluorodeoxyglucose) and active calcification (18F-sodium fluoride) of the valve leaflets. The positron emission tomography/computed tomography findings were compared in 121 patients with a full spectrum of disease severity. The authors' data have clearly established that this technique is both feasible and repeatable, indicating that these tracers may prove to be useful biomarkers of disease activity. Furthermore, the authors have demonstrated that 18F-fluorodeoxyglucose and 18F-sodium fluoride activity increase with progressive disease severity. However, uptake of 18F-sodium fluoride appears to predominate in both the early and latter stages of the disease. This may explain the disappointing effects of statin therapy in this condition and indicates that calcification might represent a better target for novel therapeutic interventions.
Conclusions: Positron emission tomography is a novel, feasible, and repeatable approach to the evaluation of valvular calcification and inflammation in patients with aortic stenosis. The frequency and magnitude of increased tracer activity correlate with disease severity and are strongest for 18F-NaF.
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Noninvasive Assessment of Myocardial Inflammation by Cardiovascular Magnetic Resonance in a Rat Model of Experimental Autoimmune Myocarditis
Summary: Myocarditis is defined as inflammation of myocardial tissue with characteristic inflammatory cellular infiltration into the myocardium. To date, reliable tools to noninvasively diagnose cellular inflammation in myocarditis are lacking. Here the authors demonstrate that the application of long-circulating magneto-fluorescent nanoparticles combined with cardiac magnetic resonance imaging permit noninvasive and robust imaging of myocardial inflammatory cellular infiltrates, enabling spatial mapping, quantification, and assessment of inflammation in experimental autoimmune myocarditis. Compared with clinically conventional cardiac magnetic resonance, magneto-fluorescent nanoparticle cardiac magnetic resonance more accurately detected scattered foci of inflammation and provided better conspicuity of small and less severe myocardial inflammation. Early and prompt diagnosis may lead to a paradigm shift in the therapeutic strategy of myocarditis. In addition, this magneto-fluorescent nanoparticle cardiac magnetic resonance approach could be an effective clinical application in monitoring the evolution of inflammation and response to antiinflammatory therapy in myocarditis. Contrast-enhancing microbubbles are used in the clinic to support visualization of cardiac structures and myocardial perfusion or to diagnose patent foramen ovale. This study substantially advances the use of microbubbles for a molecular imaging approach by their targeting, and it provides a clinically highly relevant perspective of the detection of activated platelets and thrombi in ultrasound. Successful high-resolution imaging of thrombi induced in the carotid artery of mice and monitoring of the reduction of thrombus size on pharmacological thrombolysis were achieved by coupling microbubbles with a single-chain antibody that binds to a ligand-induced binding site. The latter is exposed only on platelet receptor glycoprotein IIb/IIIa in its activated state, providing a unique target specificity, as shown with the targeted microbubbles in both mice and humans. Several potential clinical applications of this technology can be anticipated such as early detection of unstable carotid artery plaques characterized by microthrombi, visualization of thrombi in cardiac chambers, particularly in the left atrial appendage, and diagnosis of thrombi causing myocardial infarction. Furthermore, the potential to directly monitor and assess pharmacological thrombolysis in real time could provide clinically highly relevant guidance for consequent treatment. Because ultrasound is cost-effective, portable, and widely available, its application for molecular imaging using microbubbles targeted to activated platelets may provide a unique approach for the development of a rapid and noninvasive diagnosis of thrombotic diseases and for monitoring of the success or failure of thrombolysis.
Conclusions: The authors demonstrate that glycoprotein IIb/IIIatargeted MBs specifically bind to activated platelets in vitro and allow real-time molecular imaging of acute arterial thrombosis and monitoring of the success or failure of pharmacological thrombolysis in vivo. The developed approach will contribute to further optimization of novel cardiovascular cell-based treatment strategies and is of utmost importance for careful in vivo monitoring of associated risks such as potential tumor or teratoma formation.
Conclusions: This study describes for the first time the feasibility of repeated long-term in vivo imaging of viability and tissue distribution of cellular grafts in large animals. Moreover, this is the first report demonstrating vascular differentiation and long-term engraftment of hiPSCs in a large-animal model of myocardial infarction. NIS pos -hiPSCs represent a valuable tool to monitor and improve current cellular treatment strategies in clinically relevant animal models.
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Noninvasive Magnetic Resonance Imaging Evaluation of Endothelial Permeability in Murine Atherosclerosis Using an AlbuminBinding Contrast Agent
Summary: Despite the systemic and multifactorial nature of atherosclerosis, lesion development is focal and occurs at particular regions of the vasculature including the branches, the inner curvature, and the outer wall of bifurcations, where focal hemodynamic factors exert major damage on the vascular endothelium. Although several imaging modalities are now available for imaging of atherosclerosis, most of the work has focused on identifying anatomic changes associated with disease progression and risk, which have shown low predictive value. Conversely, the combination of imaging structural and functional properties of the vessel wall may allow investigation of the manner in which the extent of local artery disease is related to the degree of local abnormal endothelial function. Therefore, noninvasive physiological imaging of endothelial permeability and function may offer a comprehensive methodology for monitoring focal atherosclerotic progression in both early and later stages, as well as plaque instability, and testing the effectiveness of treatment interventions targeting vascular endothelium integrity and function.
Conclusions: The authors demonstrate the noninvasive assessment of endothelial permeability and function with the use of an albuminbinding magnetic resonance contrast agent. Blood albumin leakage could be a surrogate marker for the in vivo evaluation of interventions that aim to restore the endothelium.
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Impact of Progression of Diastolic Dysfunction on Mortality in Patients With Normal Ejection Fraction
Summary: Diastolic dysfunction is an independent predictor of mortality in patients with normal ejection fraction. Diastolic function, whether normal or abnormal (stage 1, 2, or 3), varies dynamically and can pass from 1 stage to the other and in either direction. Although worsening of diastolic function has been associated with the development of congestive heart failure, there have been limited data on mortality with this progression. The present study showed that worsening of diastolic function in outpatients with normal ejection fraction (n=1065; age, 69±13 years) was associated with increased risk of death (hazard ratio, 1.78; 95% confidence interval, 1.21-2.59; P=0.003) independently of baseline or current diastolic function. This hazard ratio was equivalent to that from worsening of systolic function in the same population. Furthermore, progression from normal to abnormal diastolic function and from stage 1 to 2 or 3 diastolic dysfunction was associated with increased mortality (hazard ratio, 3.58; 95% confidence interval, 1.71-7.53; P=0.0001; and hazard ratio, 2.13; 95% confidence interval, 1.19-3.83; P=0.01, respectively). Given the present findings, it is important for clinicians not only to recognize the importance of progression of diastolic function for their patients but also to promote aggressive risk factor modifications, particularly blood pressure control, weight loss, exercise, and salt restriction; these risk factors have traditionally have been associated with worsening of diastolic function.
Conclusions:
In patients with normal baseline left ventricular ejection fraction, worsening of diastolic function is an independent predictor of mortality. A major finding of the present investigation is that LV end-systolic dimension does not accurately reflect the extent of LV remodeling, largely because of spherical LV remodeling from the mid to apical LV by magnetic resonance imaging with 3-dimensional analysis. This study demonstrates that even when LV end-systolic dimension remains below the accepted target of 40 mm for surgical intervention of isolated mitral regurgitation, its associated LV end-systolic volume can range as high as twice that of normal control subjects. Magnetic resonance imaging with 3-dimensional analysis-or 3-dimensional echocardiography-derived LV volumes may be preferred to evaluate disease progression in isolated mitral regurgitation.
Conclusions: Despite apparently preserved LVES dimension, MR patients demonstrate significant spherical mid to apical LVES remodeling that contributes to higher LVESV than predicted by standard geometry-based calculations. Decreased LV strain after surgery suggests that a volumetric analysis of LV remodeling and function may be preferred to evaluate disease progression in isolated MR.
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Echocardiography Screening for Rheumatic Heart Disease in Ugandan Schoolchildren
Summary: The World Health Organization has made the fight against noncommunicable disease, including acquired cardiovascular disease, a top priority for the next decade. The World Heart Federation has made "eliminating rheumatic fever and minimizing the burden of rheumatic heart disease" 1 of its 6 priorities for the coming 5 years. Rheumatic heart disease affects nearly 20 million people worldwide. It disproportionately affects the developing world, causing death and disability in the prime of life. Widespread screening for rheumatic heart disease based on standardized published echocardiography-based guidelines in the most endemic regions of the developing world will be a critical component of the World Heart Federation effort. Echocardiography allows earlier detection, when penicillin remains an effective and affordable prophylaxis against progressive valvular disease.
Conclusions: This is one of the largest single-country childhood RHD prevalence studies and the first to be conducted in sub-Saharan Africa.
The authors' data support inclusion of echocardiography in screening protocols, even in the most resource-constrained settings, and identify lower socioeconomic groups as most vulnerable. Longitudinal follow-up of children with echocardiographically diagnosed subclinical RHD is needed.
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Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality
Summary: Extracellular matrix expansion may be ubiquitous in chronically diseased viable myocardium as shown by histopathologic studies in humans and animals. It is associated with mechanical, vasomotor, and electrical dysfunction and is treatable, but the relationship with outcomes has remained poorly understood. Historically, there has not been a robust noninvasive method to quantify the extent of extracellular matrix expansion in myocardium, which is often diffuse and not detectable by conventional late gadolinium enhancement imaging. Thus, the presence and extent of extracellular matrix expansion has mostly been invisible to clinicians. The authors employed novel cardiovascular magnetic resonance techniques to quantify extracellular matrix expansion by measuring the extracellular volume fraction in myocardium without myocardial infarction in a consecutive cohort of individuals referred for cardiovascular magnetic resonance. These techniques require: i) robust blood pool and myocardial T1 measurement before and after gadolinium contrast, and ii) hematocrit measurement. Extracellular volume fraction measures of the interstitial space can be embedded in clinical protocols easily and correlate highly with the collagen volume fraction in viable myocardium in most settings. In this study, extracellular matrix expansion appeared prevalent, and the extracellular volume fraction predicted both mortality and the composite endpoint of death/cardiac transplant/left ventricular assist device implantation even after adjusting for age, ejection fraction and myocardial infarction size. The apparent statistical independence of the extracellular volume fraction measure suggests a potential to improve risk stratification in patients. Further work is needed to advance understanding of the causes, consequences, and treatment of extracellular matrix expansion and myocardial fibrosis.
Conclusions: ECV measures of extracellular matrix expansion may predict mortality as well as other composite end points (death/cardiac transplant/left ventricular assist device implantation).
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Aortic Regurgitation Quantification Using Cardiovascular Magnetic Resonance: Association With Clinical Outcome
Summary: Timing surgery in patients with significant aortic regurgitation (AR) can be difficult. Currently, surgery is advised for severe regurgitation once symptoms, excess left ventricular (LV) dilation or dysfunction, occur. However, prognosis is already reduced by this stage, and earlier identification of patients suitable for surgery might be beneficial. Accurate quantification of the regurgitation may help, but is difficult with echocardiography. Cardiovascular magnetic resonance can accurately quantify AR and also provides highly accurate measurements of LV volume, but the clinical utility of this has not been established. The authors' study examined whether quantification of AR and LV volumes with cardiovascular magnetic resonance was associated with the future development of symptoms or other indications for surgery in an initially asymptomatic group with moderate to severe AR. The authors showed that both severity of AR and LV volumes had significant associations with outcome over the subsequent few years. AR quantification showed a stronger association than LV end-diastolic volume, but the combination of these 2 parameters was better still. Cardiovascular magnetic resonance measurements of AR and LV volumes might enable the identification of potential candidates for early surgery, and this should be tested in a large-scale clinical trial.
Conclusions: High degrees of CMR-quantified AR were associated with the development of symptoms or other indications for surgery. Quantifying AR showed slightly better discriminatory ability than "gold standard" CMR ventricular volume assessment. This could provide a new paradigm for the timing of surgical intervention but requires confirmation in a clinical trial.
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Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging Summary: Type 2 diabetes mellitus is associated with cardiac remodeling that may occur independently of ischemic heart disease, hypertension, or macrovascular complications. Cardiac magnetic resonance can be used to measure diabetic cardiomyopathy, for which there is currently no specific treatment. In vitro studies have shown that phosphodiesterase 5 overexpression reduces cGMP levels and exacerbates remodeling. Inhibiting cGMP hydrolysis in stimulated cardiomyocytes can prevent hypertrophy. The authors studied the effects of 3-month daily sildenafil treatment (a phosphodiesterase 5A inhibitor) on cardiac remodeling in a cohort of asymptomatic, middle-aged men with type 2 diabetes mellitus. Cardiac magnetic resonance imaging revealed that diabetic cardiomyopathy in these patients produced an uncoupling in left ventricular contraction between longitudinal strain, which is reduced, and cardiac axial rotation, which is increased. The authors found that long-term sildenafil treatment restored coupling by reducing torsion and improving strain. It also reduced the ratio of left ventricular mass to end-diastolic volume that is increased in the presence of concentric hypertrophy. These data suggest that phosphodiesterase 5 inhibition could work as an antiremodeling drug by acting directly on cardiac tissue, independently of other secondary vascular, endothelial, or metabolic effects. The authors' findings also have an impact on the clinical monitoring of patients with type 2 diabetes mellitus. The authors showed that (1) asymptomatic diabetic men may already be undergoing cardiac remodeling; (2) monocyte chemotactic protein-1 [MCP1] could be included as a new potential marker related to diabetic cardiomyopathy evolution; and (3) sildenafil can partially reverse these changes. Large-scale studies are needed to test whether phosphodiesterase 5A inhibition could become a new target for antiremodeling drugs and to discover the molecular pathways affected by this class of drugs.
Conclusions:
The early features of diabetic cardiomyopathy are LV concentric hypertrophy associated with altered myocardial contraction dynamics. Chronic phosphodiesterase type 5 inhibition, at this stage, has an antiremodeling effect, resulting in improved cardiac kinetics and circulating markers. This effect is independent of any other vasodilatory or endothelial effects and is apparently exerted through a direct intramyocardial action. 
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Summary: Rheumatoid arthritis is a systemic inflammatory condition associated with increased cardiovascular risk. This is not fully explained by traditional risk factors, but direct vascular inflammation and aortic stiffening may play a role. In this study, the authors have demonstrated that patients with rheumatoid arthritis have increased inflammation along the entire length of the aorta in comparison with age-matched patients who have cardiovascular disease and that anti-tumor necrosis factor-α therapy leads to a reduction of inflammation in the whole aorta and in the most diseased segment, as well, and to a decrease in aortic stiffness. The authors' data suggest that vascular inflammation could underpin the mechanism of increased cardiovascular disease seen in rheumatoid arthritis and propose that effective control of inflammation may reduce cardiovascular disease risk in patients with rheumatoid arthritis. Furthermore, the authors' study demonstrates that positron emission tomography/computed tomography scanning could be a useful tool for cardiovascular disease risk stratification and for monitoring risk reduction of anti-inflammatory therapies in patients with chronic inflammatory diseases.
Conclusions: This study demonstrates that RA patients have increased aortic 18F-fluorodeoxyglucose uptake in comparison with patients who have stable cardiovascular disease. Anti-tumor necrosis factor-α therapy reduces aortic inflammation in patients with RA, and this effect correlates with the decrease in aortic stiffness. These results suggest that RA patients exhibit a subclinical vasculitis, which provides a mechanism for the increased cardiovascular disease risk seen in RA. 
Conclusions:
The morphological characteristics of restenotic tissue in VL-ISR were different from those in E-ISR and similar to atherosclerotic plaque. In BMS, progression of the atherosclerotic process within neointima after stent implantation may be associated with VL-ISR.
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Comprehensive Intravascular Ultrasound Assessment of Stent Area and Its Impact on Restenosis and Adverse Cardiac Events in 403 Patients With Unprotected Left Main Disease
Summary: Although proper stent expansion is essential to prevent drug-eluting stent restenosis and thrombosis, the lack of data for the left main (LM) and both side branch ostia has limited the value of intravascular ultrasound optimization for LM stenting. A smaller minimal stent area predicted angiographic in-stent restenosis at 9 months after drug-eluting stent implantation to treat LM disease. The best minimal stent area criteria that predicted angiographic restenosis on a segmental basis were 5.0 mm2 for the left circumflex artery ostium, 6.3 mm2 for the left anterior descending artery ostium, 7.2 mm2 for the polygon of confluence, and 8.2 mm2 for the proximal LM above the polygon of confluence. Poststenting underexpansion was an independent predictor for 2-year major adverse cardiac events, especially repeat revascularization.
Conclusions: With these criteria, IVUS optimization during LMCA stenting procedures may improve clinical outcomes. 
Impact of Coronary Plaque Morphology Assessed by Optical Coherence Tomography on Cardiac Troponin Elevation in Patients With Elective Stent Implantation
Summary: Mild elevations of cardiac troponin (cTn) occur frequently after percutaneous coronary intervention (PCI), and patients with elevated biomarkers after PCI have a worse prognosis. Few studies have shown a relationship between pre-PCI lesion subsets and post-PCI cTn levels in patients undergoing elective PCI. This issue has become of particular interest after the recent release of a new universal definition of myocardial infarction (MI) that defines a rise in cTn >3 times normal after PCI as a PCI-related MI. This study used optical coherence tomography to study the relationship between pre-PCI plaque morphology and post-PCI cTnI elevations and followed outcomes to assess long-term event-free survival. One hundred thirty-one patients with normal pre-PCI cTnI levels underwent optical coherence tomography before nonemergency stent implantation. Post-PCI MI (31 patients, 23.7%) was associated with angiographic lesion length, type B2/C lesions, presence of thin-cap fibroatheroma, and fibrous cap thickness. In multivariable analysis, thin-cap fibroatheroma and type B2/C lesions were predictors of post-PCI MI. At a median follow-up of 12 months, cardiac event-free survival was significantly worse in patients with post-PCI MI (log-rank test χ2=8.9; P=0.003).
Conclusions: Type B2/C lesions and the presence of OCT-defined thin-cap fibroatheroma can predict post-PCI MI in patients treated with elective stent implantation, who may require adjunctive therapy after otherwise successful PCI. Summary: Periprocedural (Type IVa) myocardial infarction, which is a frequent complication of percutaneous coronary intervention in stable and unstable patients, has prognostic implications for longterm outcomes. Intravascular ultrasound studies suggest that larger plaque volumes with an extensive lipid core in the target lesion are related to an increased risk of periprocedural myocardial infarction. Time-domain optical coherence tomography data highlight thin-cap fibrous atheroma as a predictor of periprocedural myocardial infarction. Frequency-domain optical coherence tomography, performed both before and after percutaneous coronary intervention, confirms the presence of thin-cap fibrous atheroma and adds intrastent thrombus and intrastent dissection as independent predictors of periprocedural myocardial infarction. Tissue prolapse through stent struts not associated with periprocedural myocardial infarction.
Conclusions:
In conclusion, presence of thin-cap fibroatheroma at pre-PCI FD-OCT and of intrastent thrombus and intrastent dissection at post-PCI FD-OCT predict type IVa MI in a contemporary sample of patients treated with second-generation drug-eluting stents. Interestingly, 2 of the 3 predictors of type IVa MI were not apparent at pre-PCI FD-OCT.
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Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast Staining
Summary: Peri-stent contrast staining is found in ≈2% of lesions after sirolimus-eluting stent implantation. Peri-stent contrast staining appeared to be associated with subsequent target-lesion revascularization and very late stent thrombosis. Peri-stent contrast staining could be regarded as a relatively severe form of incomplete stent apposition. Not only incomplete stent apposition but also multiple interstrut hollows were observed in the lesions with peri-stent contrast staining assessed with optical coherence tomography. Multiple interstrut hollows is a new optical coherence tomography finding suggesting abnormal vascular reaction after sirolimus-eluting stent implantation.
Conclusions: PSS might be closely associated with 2 different optical coherence tomography findings, MIH and incomplete stent apposition, in lesions after sirolimus-eluting stent implantation. Summary: Heart failure with preserved left ventricular (LV) ejection fraction is a disease with complex pathophysiological mechanisms, for which, so far, no effective therapies have shown promise in randomized trials. In the present study, using measurements at rest with 2-dimensional speckle-tracking echocardiography, the authors have demonstrated that both the systolic and the diastolic global functions or myocardial performance of the LV (measured as the average value of peak systolic strain and peak early-diastolic strain rate in longitudinal, radial, and circumferential directions, respectively) are impaired in heart failure with preserved LV ejection fraction. Furthermore, the authors' findings suggest that an impairment of both diastolic and systolic LV myocardial performance is linked to increase in LV filling pressures, decrease in cardiac output, and worsening of New York Heart Association functional class in these patients.
Conclusions:
In patients with HFNEF, both systolic and diastolic LV myocardial performance are impaired, which is associated with increased LV filling pressures, decreased cardiac output, and worse New York Heart Association functional class. Therefore, the measurement of these myocardial parameters could be of great importance in HFNEF because these echocardiographic indices assess the multidirectional function of the whole myocardium of the LV, thereby allowing detection of an alteration of the global function of the LV which is associated with a worse symptomatic status in these patients.
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Assessing Epicardial Substrate Using Intracardiac Echocardiography During VT Ablation
Summary: Intracardiac echocardiography (ICE) is routinely used during catheter ablation for atrial fibrillation, but has not been routinely used during catheter ablation for ventricular tachycardia. There is limited information on the ability of ICE to assess for abnormal substrate during ventricular tachycardia ablation. The authors present a unique series of patients with nonischemic cardiomyopathy and recurrent ventricular tachycardia in whom ICE imaging identified abnormal echogenicity in the lateral wall of the left ventricle. Summary: The close proximity of the esophagus to the left atrium places it at risk for thermal injury during atrial fibrillation ablation procedures. Luminal esophageal temperature monitoring has been proposed as one method of reducing esophageal thermal injury. However, esophageal ulceration and atrio-esophageal fistula have been reported with the current methods used to monitor luminal esophageal temperature. In these situations, the esophageal probe can only be manipulated in a craniocaudal direction. The inability to laterally deflect current esophageal temperature probes limits their ability to detect the "hot test" spots within the esophagus. In this pilot study, the authors report a novel method of esophageal temperature monitoring with the use of a deflectable esophageal temperature probe, which, using intracardiac echocardiography guidance, was positioned in the esophageal lumen at the site closest to that where left atrial catheter ablation was performed. This approach, combined with cessation of radiofrequency catheter ablation with any 2°C rise in esophageal temperature, was used in a series of 45 patients, all of whom underwent non-symptomdriven esophageal endoscopy within 48 hours of the catheter ablation procedure. No patient had esophageal injury in this series.
Conclusions: A strategy of optimal LET probe placement using a deflectable LET probe and intracardiac echocardiography guidance, combined with cessation of radiofrequency ablation with a 2°C rise in LET, may reduce esophageal thermal injury during left atrial ablation procedures. Summary: Cardiac computed tomography (CT) is often used to noninvasively define left atrial and pulmonary venous anatomy before atrial fibrillation ablation procedures. Exposure to ionizing radiation from CT is of concern, and efforts to reduce radiation dose, while maintaining excellent image quality, are imperative. Secondgeneration 128-slice dual-source CT scanners enable ECG-triggered, single heart beat image acquisition. In the present study, use of a high-pitch protocol with dual-source CT is shown to obtain excellent quality scans with a minimal radiation dose of 1.4 mSv and scan acquisition time of only 6 seconds during sinus rhythm or atrial fibrillation. Radiation dose was markedly lower than prior non-high-pitch retrospective or prospectively triggered CT pulmonary vein scans.
Conclusions: Using a high-pitch dual-source CT protocol, PV imaging can be performed with minimal radiation dose, short scan acquisition, and excellent image quality in patients with sinus rhythm or atrial fibrillation. This protocol highlights the success of new cardiac CT technology to minimize radiation exposure, giving clinicians a new low-dose imaging alternative to assess PV anatomy.
Gaps in the Ablation Line as a Potential Cause of Recovery From Electrical Isolation and Their Visualization Using MRI
Summary: Linear ablation has become an integral part of the present ablation algorithms used to address complex arrhythmia, including atrial fibrillation and ventricular tachycardia, in patients with structural heart disease. Largely based on the authors' experience with treating cavotricuspid isthmus-dependent flutter, the value of complete transmural linear ablation producing bidirectional conduction block across the line has been established. In terms of success with ablation for atrial fibrillation, the clinical significance of gaps when they occur is moot. In this study, the authors explored the role, if any, played by remaining gaps in causing arrhythmia recurrence. The study describes and evaluates acutely established complete ablation lines, decreased conductivity in the region of gaps, and larger gaps visualized by MRI that were not obviously allowing conduction. MRI-visualized gaps potentially allowed further acute ablation that may lead to significant improvement in patient outcomes.
Conclusions: Conduction block can occur across discontinuous ablation lines. Moreover, with recovery of conductivity over time, ablation lines with large gaps exhibiting acute conduction block may recover propagation in the gap over time, allowing recurrences of arrhythmias. The ability to see gaps acutely using MRI will allow for targeting these sites for ablation.
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MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium-Enhanced 3D Scar in Patients With Implantable Cardioverter-Defibrillators
Summary: Ablation of ventricular tachycardia (VT) frequently is required in patients with recurrent implantable cardioverter-defibrillator (ICD) shocks. MRI would be uniquely positioned to characterize the complex scar substrate, which is the target of most VT ablations. However, safety of patients with ICDs and ICD artifacts on imaging quality are of clinical concern. This study demonstrates in the so-far largest published ICD cohort that cardiac MRI can be safely performed in selected patients with ICDs. Although the ICD artifacts were especially pronounced in the anterior left ventricular wall, they allowed the identification of relevant ventricular scar in all patients. Importantly, a detailed 3D model of the myocardial scar could be reconstructed and registered with the clinical mapping system to provide guidance during the VT ablation. It allowed the detection of falsely low voltage points due to suboptimal catheter contact and avoided potentially unnecessary ablation lesions. Reconstructed 3D scar images allowed the identification of successful ablation sites with only limited pace mapping in >60% of patients. Additionally, 3D MRI scar display allowed successful ablation of VT originating from a midmyocardial scar substrate, which could not be detected by voltage mapping criteria. Furthermore, surviving myocardium within left ventricular scar representing successful ablation sites could be visualized using MRI reconstructions. Successful ablation sites tended to be in the transition zones of >50% to <25% transmurality, which may allow a new imaging-guided approach to substrateguided VT ablation.
Conclusions: Contrast-enhanced cardiac MRI can be safely performed in selected patients with ICDs and allows the integration of detailed 3D scar maps into clinical mapping systems, providing supplementary anatomic guidance to facilitate substrate-guided VT ablations.
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Mapping and Ablation of the Pulmonary Veins and Cavo-Tricuspid Isthmus With a Magnetic Resonance Imaging-Compatible Externally Irrigated Ablation Catheter and Integrated Electrophysiology System
Summary: Conventional x-ray-guided fluoroscopy remains the foundation of catheter navigation in the majority of contemporary clinical electrophysiology procedures. In the past decade, magnetic resonance imaging (MRI)-guided ablation has steadily emerged as a promising alternative in interventional electrophysiology, offering potential advantages over traditional fluoroscopic guidance, including: (1) improved anatomic visualization of the heart and surrounding structures; (2) avoidance of ionizing radiation; and (3) intraprocedural visualization of lesion formation.
Conclusions: These data demonstrate the feasibility of using multiple catheters, an integrated EP pacing and recording system, and externally irrigated ablation with cardiovascular magnetic resonance guidance to undertake clinically relevant biatrial mapping and ablation.
154
Identification and Acute Targeting of Gaps in Atrial Ablation Lesion Sets Using a Real-Time Magnetic Resonance Imaging System
Summary: The goal in most ablation procedures is to electrically isolate one region from another by creating a set of contiguous and transmural ablation lesions. Yet, despite the best effort of electrophysiologists, gaps remain in ablation lesion sets. This stems from the fact that when ablating there is no direct visualization of ablation-related tissue changes and ablation is inferred based on numerous indirect parameters. Magnetic resonance imaging (MRI) has excellent soft tissue visualization characteristics, and in this study, this property of MRI was used to acutely identify ablation lesions and in turn identify the gaps between ablation lesions. A challenge in using MRI for ablation is that the currently used ablation catheters are not MRI compatible. For this study, MRI-compatible electrophysiology mapping and ablation catheters were developed. A complete real-time MRI-based electrophysiology system was also developed by integrating the use of MRI-compatible catheters with real-time imaging. This system was used to acutely identify the ablation lesions, the gaps in between the lesions, and then target the gaps acutely.
Conclusions: RT-MRI system can be used to identify and acutely target gaps in atrial ablation lesion sets. Acute targeting of gaps in ablation lesion sets can potentially lead to significant improvement in clinical outcomes.
155
Acute Pulmonary Vein Isolation is Achieved by a Combination of Reversible and Irreversible Atrial Injury after Catheter Ablation: Evidence from Magnetic Resonance Imaging
Summary: Single ablative therapy for paroxysmal atrial fibrillation has moderate success, and many patients present with recurrent arrhythmia. The authors proposed that the structure of the radiofrequency lesion applied during ablation is important in determining recurrences. The nature of the radiofrequency lesion was studied using magnetic resonance imaging with gadolinium-enhanced imaging and high-signal T2-weighted imaging. Twenty-five patients underwent magnetic resonance imaging scans for delayed enhancement (DE) and T2 at 3 time points: before ablation, within 24 hours, and 6 months after ablation. Patients were divided into those with (n=11) and without (n=14) recurrent arrhythmia. Levels of DE+T2 were low in preprocedural scans but rose dramatically immediately after the procedure. Acute DE was greater in patients without recurrences compared with those with recurrences. Conversely, T2 levels were lower in patients without recurrences and higher in those with recurrences. On the late scans, T2 reduced to baseline. DE, however, remained and was greater in patients without recurrences. We, therefore, propose that acute radiofrequency ablation injury is composed of 2 types of tissue damage. DE infers largely necrotic tissue injury, which lasts longer and causes persistent conduction block. T2 is a transitory phenomenon coexisting with DE, causing acute conduction block. The authors propose that resolution of the T2 signal is associated with recurrences of pulmonary vein connection and, therefore, arrhythmia recurrences. Modifications in the authors' ablative techniques to achieve more DE at the acute ablation would potentially be important in conferring a better ablation outcome.
Conclusions:
The higher T2 signal on acute scans and greater decline in DE on chronic imaging in patients with recurrences suggest that they have more reversible tissue injury, providing a potential mechanism for pulmonary vein reconnection, resulting in arrhythmia recurrence.
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Dyssynchrony, Contractile Function, and Response to Cardiac Resynchronization Therapy
Summary: Although cardiac resynchronization therapy (CRT) has been shown to reduce cardiovascular outcomes in patients with heart failure and left ventricular dysfunction, almost one-third of patients who receive CRT do not respond to treatment. Determining which patients are more or less likely to benefit from CRT remains a therapeutic challenge. Left ventricular mechanical dyssynchrony has been suggested as a method for overcoming the limitations of estimating electric dyssynchrony. Echocardiographic assessments of both left ventricular mechanical dyssynchrony and discrete contractile function, which can reflect the extent of myocardial viability and scar burden, now can be performed in a highly reproducible and angle-independent manner by using speckle-tracking analysis. Therefore, in a sample of 1077 patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial, the authors used echocardiographic myocardial deformation analyses to investigate whether or not mechanical synchrony and contractility might predict response to CRT. The authors observed that the combination of mechanical dyssynchrony and preserved contractile function significantly predicted lower risk for recurrent heart failure or death after CRT, even after adjusting for factors conventionally associated with CRT response. The authors' results indicate that the ventricle must be dyssynchronous but also viable, as reflected by contractile function, to benefit from CRT. These findings suggest that mechanical dyssynchrony and contractile function may be more directly related to clinical response and outcomes than conventionally measured electric dyssynchrony. The authors' analyses were strengthened by the availability of a large sample size, data on long-term clinical outcomes, and the presence of a control group that allowed estimation of the treatment effect.
Conclusions: Both mechanical dyssynchrony and contractile function are important independent correlates of benefit from CRT. Summary: Identifying the optimal fluoroscopic projection of the aortic valve is important for successful transcatheter aortic valve replacement. The most common approach is to perform repeated aortic root injections, which may be time-consuming, increase radiation exposure, and require large amounts of radiographic contrast. Aortic root reconstructions from multidetector computed tomography have been shown to be helpful in predicting perpendicular valve view angles for accurate prosthesis positioning. The authors' study demonstrates that 3-dimensional reconstructions of the aortic root generated from in-laboratory, on-line C-arm rotational angiography accurately determine fluoroscopic projections perpendicular to the plane of the native valve. This new method automatically identifies the aortic cusps and the perpendicular valve view, requires less radiographic contrast than multidetector computed tomography, and proved to be accurate.
Conclusions: Three-dimensional angiographic reconstructions and MDCT are safe, practical, and accurate imaging modalities for identifying the optimal perpendicular valve deployment projection during TAVR. Summary: This study evaluated ECG-gated contrast-enhanced computed tomography to assess left atrial anatomy in patients referred for catheter ablation of atrial fibrillation. Left atrial diverticula are common anatomic variants in these patients. Thin-walled left atrial diverticula have different shapes. Tubiform left atrial diverticula with a long and tortuous body are possible sites for catheter ablation of atrial fibrillation; they theoretically could contribute to complications such as thrombus formation or catheter entrapment. Because most left atrial diverticula are thin-walled, this results in a potentially vulnerable area of the left atrium for perforation during catheter ablation. Dual-source computed tomography is useful to identify the presence and imaging features of left atrial diverticula before the ablation procedure to prevent potential catheter ablation-related complications.
Conclusions: LAD are common, with a prevalence of 36.0% in patients with AF, which is not statistically greater than that in patients without AF. Thin-walled LAD are more commonly located on the superior anterior wall of left atrium and close to common ablation sites. The hallmark pathological lesion of arrhythmogenic right ventricular cardiomyopathy (ARVC) is myocardial loss with replacement by fibrofatty tissue. RV lesions are assessed as mechanical wall dysfunction by traditional imaging techniques, such as echocardiography and angiography. Emerging tools offer the possibility to directly visualize a fibrofatty ventricular scar. Endocardial voltage mapping (EVM) by the CARTO system has been demonstrated to identify "low-voltage" myocardial areas ("electroanatomical scar") invasively, whereas contrast-enhanced cardiac magnetic resonance (CE-CMR) has the potential to detect regions of delayed contrast enhancement (DCE) noninvasively. The potential utility of such imaging approaches is still under evaluation, and their use for detection of ventricular scar has not been included among the recently revised task force diagnostic criteria for ARVC. The authors' study was designed to evaluate the diagnostic accuracy of direct visualization of a ventricular scar and to compare the ability of EVM and CE-CMR for imaging scar lesions in ARVC. The study demonstrates that EVM allows accurate identification of RV electroanatomical scars in ARVC patients and supports its clinical use for substrate-based mapping and catheter ablation of RV tachycardias, as well as for imaging-guided endomyocardial biopsy. On the contrary, available DCE-CMR appears less sensitive in visualizing RV scars, limiting its usefulness for clinical diagnosis and for guiding interventional RV procedures. Of interest, the high prevalence of left ventricular DCE in the study patients is in keeping with the perspective of biventricular disease involvement and indicates the diagnostic relevance of left ventricular scar detection by CE-CMR resonance in ARVC patients.
Conclusions: EVM and CE-CMR allow identification of RV scar lesions in most ARVC patients. CE-CMR is less sensitive than EVM in identifying RV scar lesions. The high prevalence of LV DCE confirms the frequent biventricular involvement and indicates the diagnostic relevance of LV scar detection by CE-CMR. Summary: Radiofrequency catheter ablation is useful to reduce episodes of sustained monomorphic ventricular tachycardia (VT) in patients with implantable defibrillators and prior myocardial infarction. Hemodynamic instability often limits mapping during VT, and identification of potential reentry circuit substrate by mapping during sinus or paced rhythm is often used to guide ablation in these patients. The authors sought to quantify the association of reentry circuit sites with magnetic resonance myocardial image characteristics to gain insights regarding the anatomy of tissues and critical sites that support postinfarct VT. In a series of 23 patients, the authors found that critical VT sites were associated with >25% scar transmurality and central VT circuit sites were associated with >75% scar transmurality. In addition, left ventricular wall thickness, postinfarct scar thickness, and intramural scar location were associated with local intracardiac electrogram amplitudes, duration, and deflections. These findings demonstrate the feasibility of creating noninvasive image-based maps before the procedure, which can potentially be used to guide VT substrate ablation.
Conclusions:
Critical sites for maintenance of postinfarct VT are confined to areas with >25% scar transmurality. The authors' data provide insights into the structural substrates for delayed conduction and VT and may reduce procedural time devoted to substrate mapping, overcome limitations of invasive mapping because of sampling density, and enhance magnetic resonance-based ablation by feature extraction from complex images. 161 
